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Epilepsy is the fourth most common neurological disease in the United States, which is 
characterized by the recurrent seizures in unpredictable frequency with a range of severities and 
a variety of causes. About 3.4 million people in the United States have epilepsy. Every year, 
there is an increase of 150,000 of new cases and about 50,000 people die from epilepsy-related 
causes. Moreover, one in twenty-six of the people in the United States will develop epilepsy 
during their lifetime. Last but not least, one-third of the patients are drug-resistant. Even for 
those patients whose seizures could be controlled with medications or other treatments, living 
with epilepsy is still a big challenge, as they need to face questions about independent 
capabilities, limitation on driving and uncertainties in employment situations. The overall quality 
of life and productivity of people with epilepsy and their families need to be improved. 
Therefore, studying the mechanisms of epileptogenesis is significant to develop better treatments 
or cure for epilepsy patients. 
Many patients with neurological disorders suffer from an imbalance in neuronal and 
circuit excitability and present with seizure or epilepsy as the common comorbidity. The onset of 
epilepsy can be a result of an acquired brain injury (such as a trauma) or a genetic mutation in 
some genes. It is widely accepted that the alterations in activity, composition or distribution of 
ion channels caused by genetic mutations contribute to the onset of epilepsy. DNA sequencing 
and analysis performed as part of a worldwide research study called Epilepsy 4000 (Epi4k) has 
revealed over 300 de novo mutations in patients with epilepsy. Among those genes identified, the 
neural precursor cell expressed developmentally down-regulated gene 4-2, Nedd4-2, was 
specifically noted. Furthermore, three missense changes in Nedd4-2 have also been identified in 
families with epilepsy. Nedd4-2 gene encodes a ubiquitin E3 ligase that has high affinity toward 
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binding and ubiquitinating membrane proteins, including ion channels. However, it is currently 
unknown how Nedd4-2 mediates neuronal circuit activity and how its dysfunction leads to 
seizures or epilepsies. During my Ph.D. thesis studies, I aimed to characterize the function of 
Nedd4-2 in regulating neuronal excitability and how epilepsy-associated missense mutations 
impair such regulation, in order to elucidate the molecular mechanisms underlying Nedd4-2-
mediated epileptogenesis. 
Several neuronal ion channels have been reported as the novel substrates of Nedd4-2, 
including the major subunit (GluA1) of an ionotropic glutamate receptor, alpha-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor, which our lab has identified. 
AMPA receptors (AMPARs) are the most commonly found receptors in the mammalian nervous 
system, mediating fast excitatory synaptic transmission. Their distribution and activity are 
regulated by post-translational modifications, such as ubiquitination and phosphorylation. 
Studies have shown that GluA1 ubiquitination contributes to its internalization, which, as part of 
AMPAR trafficking mechanisms, is critical for synaptic depression as well as homeostatic 
regulation of synaptic strength. Because GluA1 levels affect neuronal activity, and dysregulation 
of AMPARs has been shown to be linked to epilepsy, we hypothesize that Nedd4-2 plays a role 
in down-regulating neuronal excitability through fine-tuning of AMPARs, specifically 
ubiquitinating and degrading GluA1. 
In Chapter Two, we studied the role of Nedd4-2 in regulation of neuronal activity. Using 




in which one of the major forms of Nedd4-2 in the 
brain is selectively deficient, we first demonstrated that Nedd4-2 is involved in the regulation of 
neuronal network excitability. Measured by a multi-electrode array (MEA) system, the 
spontaneous neuronal activity in Nedd4-2
andi
 cortical neuron cultures was basally elevated 
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compared to wild-type (WT) cultures. Subsequently, our data indicated that when 
pharmacologically modulating AMPAR activities, Nedd4-2
andi
 cultures showed less responsive 
to AMPAR activation, and much more sensitive to AMPAR blockade. Moreover, when 
performing kainic acid-induced seizures in vivo, we found that elevated seizure susceptibility in 
Nedd4-2
andi
 mice could be normalized when GluA1 is genetically reduced. 
In Chapter Three, we focused on characterizing the epilepsy-associated mutations of 
Nedd4-2. Three Nedd4-2 missense changes in highly conserved residues (S233L, E271A and 
H515P) were identified in families with epilepsy. Based on our previous findings, we aimed to 
test the hypothesis that one or more of these mutations could disrupt GluA1 ubiquitination and 
degradation, resulting in dysregulation of neuronal excitability. To begin with, I generated 
corresponding Nedd4-2 variants in Nedd4-2 cDNA construct by Site-Directed Mutagenesis. My 
evidence from HEK cells showed that GluA1 was less ubiquitinated when co-expressed with any 
of the Nedd4-2 mutants in comparison to WT Nedd4-2. Similar result was observed by in vitro 
ubiquitination assay as well. Apart from GluA1 ubiquitination, its degradation was also affected 
by the mutant Nedd4-2s, as GluA1 showed enhanced half-life when co-expressed with any of the 
Nedd4-2 variants compared to WT Nedd4-2. Furthermore, three epilepsy-associated missense 
mutations of Nedd4-2 also failed to reduce GluA1 surface expression or spontaneous neuronal 
activity when compared to WT Nedd4-2. Collectively, our data suggest that impaired GluA1 
ubiquitination contributes to Nedd4-2-dependent neuronal hyperactivity and seizures. These 
findings provide critical information to the future development of therapeutic strategies for 
patients who carry mutations of Nedd4-2. 
In Chapter Four, in collaboration with Dr. Kwan Young Lee, a research scientist in Tsai 
lab, I extended my studies on the function of two major isoforms of Nedd4-2, C2-containing and 
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C2-lacking isoforms, in regulating excitatory synaptic strength. Because single-nucleotide 
polymorphisms (SNPs) in human Nedd4-2 lead to differential expression of these two isoforms, 
examining their functional differences may aid our understanding of neuronal excitability 
regulation and seizure susceptibility in different populations. As the C2 domain is responsible for 
binding to membranes, we first found that the C2-lacking Nedd4-2 showed a reduced distribution 
at cell membranes and extremely low affinity in ubiquitinating GluA1. However, meanwhile, the 
C2-lacking Nedd4-2 exhibits similar activity toward reducing excitatory synaptic strength when 
compared to the C2-containing Nedd4-2. Using proteomic screening, we identified multiple 
potential substrates of the C2-lacking Nedd4-2 in the cytoplasm, including PPP3CA (a subunit of 
calcineurin A), that could mediate excitatory synaptic strength. We then confirmed that PPP3CA 
is a substrate of C2-lacking Nedd4-2 in HEK cells, as well as by in vitro ubiquitination assay. In 
addition, the epilepsy-associated mutations in C2-lacking Nedd4-2 showed impaired PPP3CA 
ubiquitnation. Further studies will be definitely needed to fully characterize the properties and 
regulation of this Nedd4-2 isoform. 
In summary, in this dissertation, I studied the molecular mechanisms by which Nedd4-2 
gene is associated with epileptogenesis, and provided evidence showing Nedd4-2-associated 
neuronal hyperexcitability and seizure susceptibility are critically influenced by elevated 
excitatory synaptic transmission when the functions of Nedd4-2, both C2-containing and C2-
lacking isoforms, are compromised. These findings in my dissertation may facilitate the future 
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Background and Significance 
1.1 Introduction 
1.1.1 Epilepsy 
Epilepsy is a spectrum of disorders characterized by the propensity to experience 
recurrent unprovoked seizures. As reported by the Centers for Disease Control and Prevention 
(CDC) in 2015, it is the fourth most common neurological disorder in the United States, 
affecting around 3.4 million people. An epileptic seizure is an unpredictable interruption of 
normal brain function, due to abnormal excessive or synchronous neuronal activity in the cortex 
of the brain (Fisher et al, 2005). Therefore, epilepsy is considered as a hyperexcitability-
associated neurological disorder, potentially resulting from an improper homeostatic control of 
neuronal activity, as proposed previously (Seeburg & Sheng, 2008). In fact, many patients suffer 
from an imbalance in neuronal and circuit excitability and present with seizure or epilepsy as the 
common comorbidity. 
The causes of epilepsy can vary from brain injuries or tumors to birth defects. Meanwhile, 
genetic factors also play a role in many cases, either because the underlying cause of epilepsy is 
primarily genetic or because genes can modulate susceptibility to an epileptogenic insult 
(Pandolfo, 2011). However, the mechanisms of how seizures initiate and propagate are 
incompletely understood (Pearson-Smith & Patel, 2017). Current literatures suggest that the 
alterations in activity, composition or distribution of ion channels, caused by genetic mutations, 
contribute to the pathophysiology of epilepsy (Bongiorno et al, 2011). There are many epilepsy-
associated genes identified by human genetic studies, with evidence showing some of those 
2 
 
genes encoding ion channels or their regulators in the etiology of those pathophysiological 
conditions (Grant, 2012; Zoghbi & Bear, 2012). However, the pathways by which those genes 
are connected to brain circuit excitability are largely unknown. Characterizing those genes and 
their function in regulation of brain circuit activity is likely to reveal novel therapeutic targets for 
these diseases. 
 
1.1.2 Nedd4-2 and its substrates 
DNA sequencing and analysis performed as part of a worldwide research study called 
Epilepsy 4000 (Epi4k) has revealed 329 de novo mutations in patients with epilepsy (Allen et al, 
2013). One of those genes is the neural precursor cell expressed developmentally down-regulated 
gene 4-like (Nedd4-2) (Allen et al, 2013). Nedd4-2, is an epilepsy-associated gene containing at 
least three missense mutations identified through genomic mutation screening in patients with 
epilepsy (Allen et al, 2013; Dibbens et al, 2007; Vanli-Yavuz et al, 2014; Wu et al, 2015). It 
encodes a ubiquitin E3 ligase that belongs to the Nedd4 family of ubiquitin E3 ligases (Yang & 
Kumar, 2010) but is the only member encoded by an epilepsy-associated gene (Allen et al, 2013). 
The Nedd4 family members are characterized by a unique modular domain architecture 
comprised of an N-terminal Ca
2+
-phospholipid-binding (C2) domain, 2 to 4 WW domains and 
the HECT (Homologous to the E6-AP Carboxyl Terminus) domain at the C-terminus (Fig. 1.1) 
(Goel et al, 2015). The C2 domain is responsible for binding lipid membranes but has also been 
reported to bind proteins (Scheffner & Kumar, 2014). The WW domains, composed of 35-40 
amino acids, including two conserved tryptophan residues (Andre & Springael, 1994; Hofmann 
& Bucher, 1995), are modular protein domains which mediate specific interactions between 
substrates and regulatory proteins through binding to their PY motifs. Given the presence of four 
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WW domains in Nedd4-2, the substrate recognition and the underlying regulation are 
complicated (Yang & Kumar, 2010). The HECT domain is a bilobular catalytic domain, with the 
C lobe containing the acceptor cysteine residue and the N lobe interacting with the ubiquitin-
charged E2 enzymes (Maspero et al, 2013; Rotin & Kumar, 2009). Because of these functional 
domains, Nedd4-2 has a high affinity for ubiquitinating membrane proteins, often labeling them 
for endocytosis and lysosomal/proteasomal destruction, which affects their cell surface density 
(Dibbens et al, 2007). 
One of the most studied targets of Nedd4-2 is the epithelial sodium channel (ENaC) in 
the kidney (Harvey et al, 2001; Kamynina et al, 2001). Nedd4 and Nedd4-2 have been proposed 
to down-regulate sodium channel activity in response to increases in intracellular Na
+
 (Dinudom 
et al, 1998; Goulet et al, 1998; Harvey et al, 2001; Harvey et al, 1999; Harvey & Kumar, 1999) 
by ubiquitination of the channel (Goulet et al, 1998; Kamynina et al, 2001; Staub et al, 1996; 
Staub et al, 1997), leading to its endocytosis and degradation (Goulet et al, 1998; Staub et al, 
1997). Additionally, multiple ion channels and transporters associated with neuronal excitability 
have been shown to interact with Nedd4-2 and be ubiquitinated, including the glutamate 
transporters EAAT1 and EAAT2 (Boehmer et al, 2003; Boehmer et al, 2006) and the voltage-
gated potassium channel Kv1.3 (Henke et al, 2004). In vivo studies have also shown that Nedd4-
2 regulates the cell surface levels of neuronal voltage-gated sodium channels (VGSCs) expressed 
in Xenopus oocytes (Fotia et al, 2004). However, although Nedd4-2 is capable of ubiquitinating 
VGSCs, which are critical for controlling neuronal excitability (Zuliani et al, 2009), the 
identified Nedd4-2 missense mutations in families with photosensitive generalized epilepsy do 
not affect the physiological properties of the VGSC (Vanli-Yavuz et al, 2015). Therefore, the 
mechanism by which Nedd4-2 is associated with epileptogenesis is currently unknown. 
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Several more neuronal membrane substrates of Nedd4-2 have been identified, such as 
voltage-gated sodium channel Nav1.6 (Ekberg et al, 2014), voltage-gated potassium channels 
Kv7/KCNQ (Ekberg et al, 2007; Goel et al, 2015; Schuetz et al, 2008), neurotrophin receptor 
TrkA (Georgieva et al, 2011; Yu et al, 2014) and the GluA1 subunit of the α-amino-3-hydroxy-
5-methyl-4-isoxazolepropionic acid receptor (AMPAR) (Jewett et al, 2015b). Our previous work 





one of the major forms of Nedd4-2 in the brain is selectively deficient (Jewett et al, 2016). 
Presumably wild-type (WT) Nedd4-2 mediates or represses circuit activity by ubiquitinating one 
or more of its substrates while the epilepsy-associated mutants fail to do so and lead to seizures 
and/or epilepsies. To test this possibility, we needed to identify the relevant substrate of Nedd4-2 
in regulation of neuronal excitability and characterize the effect of epilepsy-associated mutations 
on substrate ubiquitination and degradation. 
 
1.1.3 The regulation of excitatory synapses and AMPA receptors 
As mentioned earlier, epilepsy is considered as hyperexcitability-associated neurological 
disorder, potentially resulting from an improper homeostatic control of neuronal activity 
(Seeburg & Sheng, 2008). Therefore, the onset of epilepsy is closely related to the dysregulation 
of excitatory synapses. 
Hippocampal pyramidal neurons are the most numerous excitatory cell type in 
mammalian cortical structures. They have a distinct pyramidal-shaped cell body as well as an 
extensively-branched single axon and two separate dendritic trees (basal and apical) (Spruston, 
2009). The dendrites of pyramidal neurons are regarded as input structures, receiving signals 
from other neurons through chemical synapses, while the axon functions as an output structure 
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(Spruston, 2008). At a chemical synapse, electrical activity in the presynaptic neuron is 
converted into the release of neurotransmitter which can bind to receptors located on the cell 
membrane of the postsynaptic cell. This will then trigger an electrical response or a secondary 
messenger pathway that either excites or inhibits the postsynaptic neuron. Chemical synapses 
can be classified according to the neurotransmitter released, where glutamatergic synapses are 
often excitatory . 
The AMPAR is a major subtype of ionotropic transmembrane glutamate receptors and is 
the most commonly found receptor in the mammalian nervous system (Bowie, 2012; Hall & 
Ghosh, 2008). AMPARs are assembled as homo-or hetero-tetramers and are comprised of 
combinations of GluA1–GluA4 subunits (Nakagawa, 2010). In central nervous system, they 
mediate fast excitatory synaptic transmission and postsynaptic depolarization upon binding to 
glutamate available at the synaptic clefts or released from presynaptic terminals. The level and 
distribution of AMPARs affect the strength of glutamatergic synapses and therefore are crucial 
to synaptic plasticity (Lee, 2016). Synaptic plasticity is the process by which synaptic 
transmission is strengthened or weakened in response to specific patterns of activity (Fig. 1.2) 
(Henley & Wilkinson, 2016). In general, increased AMPAR function results in long-term 
potentiation (LTP), the process in which synaptic transmission is persistently strengthened. On 
the contrary, decreased AMPAR function leads to long-term depression (LTD) (Shepherd & 
Huganir, 2007).  
The regulation of AMPARs, through post-translational modifications, is important in 
maintaining normal synaptic functions under physiological conditions, and dysregulation of 
AMPARs has been shown to be linked to epilepsy (Bateup et al, 2013; Rogawski & Donevan, 
1999). Each subunit of AMPAR has a non-conserved C-terminus, an intracellular domain that 
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harbors regulatory elements subject to various post-translational modifications such as 
ubiquitination. All four AMPAR subunits can be ubiquitinated, but only GluA1 ubiquitination 
has been specifically described upon different activity stimulations (Fu et al, 2011; Widagdo et al, 
2015). Studies have shown that GluA1 ubiquitination contributes to its internalization (Lin et al, 
2011; Schwarz et al, 2010). This internalization, as part of AMPAR trafficking mechanisms 
(Malenka, 2003), is critical for synaptic depression as well as homeostatic regulation of synaptic 
strength (Anggono et al, 2013; Glebov et al, 2015; Henley et al, 2011; McCartney et al, 2014). 
Because GluA1-GluA2 is the predominant AMPAR heteromer (Lu et al, 2013), and GluA1 is 
required for successful trafficking and targeting of GluA2 (Zamanillo et al, 1999), we 
hypothesize that Nedd4-2 is required for limiting GluA1 surface expression and functionality of 
AMPAR. In addition, Nedd4-2 may play a role in affecting neuronal activity, seizures, and/or 
epilepsy through fine-tuning of AMPARs. 
 
1.1.4 The ubiquitination/ubiquitin proteasome system (UPS) 
Ubiquitination is a post-translational modification that regulates various physiological 
pathways, such as the degradation, endocytosis, recycling, sorting, and trafficking of proteins 
(Hershko & Ciechanover, 1998). It involves a covalent attachment of ubiquitin, a highly 
conserved 76-amino-acid molecule, to a lysine residue on the substrate protein. The number of 
attached ubiquitin molecules determines the fate of the substrate: the addition of one ubiquitin 
molecule, known as mono-ubiquitination, usually leads to changes in the protein’s subcellular 
localization, whereas the formation of a chain of ubiquitins at a specific lysine residue on the 
substrate, known as poly-ubiquitination, often results in the proteasome-associated degradation 
of the protein (Ikeda & Dikic, 2008). The ubiquitination process consists of three major steps, 
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which are catalyzed by three different enzymes (Fig. 1.3): activation of ubiquitin by an E1 
ubiquitin-activating enzyme, conjugation to an E2 ubiquitin-conjugating enzyme, and, finally, 
targeting the substrate with ubiquitin by an E3 ubiquitin ligase (Hershko & Ciechanover, 1998). 
It is the E3 ligase that determines the substrate specificity as it recognizes and binds the 
substrates to be ubiquitinated. The substrate-targeting step, which involves E3 ligases, is also the 
rate-limiting step during ubiquitination. There are roughly over 600 putative E3 ligases encoded 
in the human genome (Li et al, 2008), which are divided into two major families of enzymes: the 
homologous to E6-AP C-terminus (HECT) family E3 enzymes, which accept ubiquitin from the 
E2 enzyme and then transfer it to the substrate; and the really interesting new gene (RING) 
family E3 enzymes, which act as scaffolds to facilitate the direct transfer of ubiquitin from the 
E2 enzyme to the substrate (Metzger et al, 2012) (Fig. 1.4). A third family, the RING-Between-
RING (RBR) family E3 enzymes, has recently been established. The members of the RBR E3 
enzyme family, a much smaller family in comparison to HECT and RING families, function as 
RING/HECT hybrids by utilizing their RING domains to interact with E2-Ub but mediate the 
transfer of ubiquitin through an E3-Ub intermediate complex (reviewed by (Reiter & Klevit, 
2018)). 
The ubiquitin proteasome system plays several important roles in maintaining protein 
homeostasis in a cell, including clearing misfolded proteins, recycling receptors on the cell 
membrane, and sorting and trafficking signaling molecules (Popovic et al, 2014). In neurons, the 
UPS also provides the fundamental basis for executing neuron-specific activities, such as 
regulating the transport and homeostasis of ion channels, the dynamics of synaptic vesicles, and 
synaptic plasticity (Okerlund et al, 2017; Saavedra et al, 2019; Sun et al, 2018). Through the 
study of protein compositions at the post-synaptic density and the turnover of glutamate 
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receptors and scaffolding proteins in neurons, researchers have also shown that ubiquitination 
and ubiquitin-mediated degradation are both required during activity-dependent synaptic 
remodeling (Ehlers, 2003; Hung et al, 2010; Kerrisk Campbell & Sheng, 2018; Patrick et al, 
2003). Furthermore, the UPS is also involved in neuronal adaptation and survival upon 
environmental challenges (Hochrainer, 2018; Rotin & Staub, 2011; Xiao et al, 2018). Because of 
these crucial functions, disruptions in protein ubiquitination or UPS in neurons often lead to 
impaired synaptic transmission or excitability homeostasis and subsequently to seizures and 
epilepsies (Hall et al, 2017; Macdonald & Kang, 2012; Widagdo et al, 2017). 
Therefore, in order to study the molecular mechanisms by which Nedd4-2 gene is 
associated with epileptogenesis, we would focus on three specific research aims: characterizing 
the role of Nedd4-2 in regulation of neuronal excitability, characterizing three epilepsy-
associated missense mutations of Nedd4-2, as well as characterizing how two isoforms of 
Nedd4-2 contribute to the regulation of neuronal excitability. Successfully dissecting the 
mechanisms by which Nedd4-2 regulates AMPARs and neuronal excitability will significantly 










Fig. 1.1 A schematic structure of Nedd4-2 and the location of the three residues of epilepsy-
associated missense mutations. 
All three residues of epilepsy-associated mutations are located on or near one of the protein-protein 








Fig. 1.2 A widely accepted model of LTP and LTD. 
AMPA receptors (AMPARs) can laterally diffuse within the plasma membrane and be trapped at 
synapses by slot proteins (not shown) at the postsynaptic membrane. The number of AMPARs at 
synapses is also dependent on relative rates of their exocytosis and endocytosis at the 
postsynaptic membrane. Induction of LTP (up right) increases the AMPAR exocytosis, while 











Fig. 1.3 The ubiquitination pathway. 
The pathway starts with an ATP-dependent activation of ubiquitin (Ub) by an E1 ubiquitin-activating 
enzyme (E1). An E2 ubiquitin-conjugating enzyme subsequently catalyzes the transfer of the ubiquitin 
molecule from an E1 to an E2. When an E3 ligase (E3) recognizes its substrate, the Ub is transferred from 
E2 to the substrate on specific lysine residues. Depending on the repeats of this ubiquitination pathway, a 










Fig. 1.4 The ubiquitination mediated by RING or HECT family E3 ligases. 
Once the E2 ubiquitin-conjugating enzyme is charged with ubiquitin, the E3 ligase will facilitate the 
ubiquitin transfer to the target protein. There are two major ubiquitin E3 ligase families, characterized by 
two different mechanisms of the ubiquitin transfer process. The really interesting new gene (RING) 
family E3 enzymes (shown in green) mediate the direct transfer of ubiquitin by serving as a docking site 
for E2 enzymes and recruiting the substrates close to E2. The homologous to E6-AP C-terminus (HECT) 
family E3 enzymes (shown in purple) use a catalytic cysteine residue to form a thioester bond with the 
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The role of Nedd4-2 in regulation of neuronal excitability 
[Zhu J, Lee KY, Jewett KA, Man HY, Chung HJ, Tsai NP (2017) Epilepsy-associated gene 
Nedd4-2 mediates neuronal activity and seizure susceptibility through AMPA receptors. PLoS 
Genet. 13: e1006634] 
2.1 Introduction 
As mentioned in Chapter One, the neural precursor cell expressed developmentally 
down-regulated gene 4-2, Nedd4-2, is an epilepsy-associated gene with at least three missense 
mutations identified in epileptic patients (Dibbens et al, 2007; Vanli-Yavuz et al, 2015). Nedd4-2 
encodes a ubiquitin E3 ligase that has high affinity toward binding and ubiquitinating membrane 
proteins (Itani et al, 2005). However, it is currently unknown how Nedd4-2 mediates neuronal 
circuit activity and how its dysfunction leads to seizures or epilepsies. 
In this chapter, I provided evidence to show that Nedd4-2 mediates neuronal activity and 
seizure susceptibility through ubiquitination of GluA1 subunit of the α-amino-3-hydroxy-5-





in which one of the major forms of Nedd4-2 in the brain is selectively deficient, I found that 
the spontaneous neuronal activity in Nedd4-2
andi
 cortical neuron cultures, measured by a 
multiunit extracellular electrophysiology system, was basally elevated, less responsive to 
AMPAR activation, and much more sensitive to AMPAR blockade when compared with wild-
type cultures. When performing kainic acid-induced seizures in vivo, I showed that elevated 
seizure susceptibility in Nedd4-2
andi
 mice was normalized when GluA1 is genetically reduced. 
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To our knowledge, these findings provide the first mechanism underlying Nedd4-2-
associated circuit hyperactivity and seizures and open up a new avenue for the development of 
therapeutic strategies to potentially treat epileptic patients who carry Nedd4-2 mutations. 
 
2.2 Materials and Methods 
2.2.1 Animals and primary cortical neuron cultures 
The Nedd4-2
andi
 mice, GluA1 knockout mice and WT control mice were obtained from 
The Jackson Laboratory. Primary cortical neuron cultures were made from p0-p1 mice as 
described previously (Tsai et al, 2012) and maintained in NeuralQ basal medium (Sigma) 
supplemented with 1X B27 supplement (Invitrogen), 1X GlutaMax (final concentration at 2 mM; 
Invitrogen), and Cytosine β-D-arabinofuranoside (AraC, final concentration at 2 µM; Sigma). 
The medium was changed 50% on DIV 2 and every 3 days thereafter. All experiments using 
animal data followed the guidelines of Animal Care and Use provided by the Illinois Institutional 
Animal Care and Use Committee (IACUC) and the guidelines of the Euthanasia of Animals 
provided by the American Veterinary Medical Association (AVMA) to minimize animal 
suffering and the number of animals used. This study was performed under an approved IACUC 
animal protocol of University of Illinois at Urbana-Champaign (#14139 to N.-P. Tsai). 
 
2.2.2 Reagents 
Dimethyl sulfoxide (DMSO) was from Fisher Scientific. AMPA was from Cayman 





2.2.3 MEA recording 
Each MEA plate was coated with poly-D-lysine for 30 minutes and plated with 2x10
5
 
cells counted using a hemocytometer. Recordings were done at DIV 13-14 (Figs. 2.1, 2.3 and 2.5) 
in the same culture medium using an Axion Muse 64-channel system in single well MEAs (M64-
GL1-30Pt200, Axion Biosystems) inside a 5% CO2, 37°C incubator. Field potentials (voltage) at 
each electrode relative to the ground electrode were recorded with a sampling rate of 25 kHz. 
Right before a recording, if an electrode channel displays excessive “noise” (>10 µV) that 
channel is grounded for the entirety of the recording to avoid interference with other channels 
(McConnell et al, 2012). After 30 min of baseline recording, the MEA was treated with the drugs 
specified and recorded for another 30 min. Due to changes in network activity caused by 
physical movement of the MEA, only the last 15 min of each recording were used in data 
analyses. AxIS software (Axion Biosystems) was used for the extraction of spikes (i.e. action 
potentials) from the raw electrical signal obtained from the Axion Muse system. After filtering, a 
threshold of ±7 standard deviations was independently set for each channel; activity exceeding 
this threshold was counted as a spike. Only MEAs with more than 2,000 spikes during the last 15 
minutes of recording were included for data analysis (Jewett et al, 2016; Jewett et al, 2015a). The 
total spikes obtained from each MEA culture was normalized to the number of electrodes, as 
described in a previous study (McSweeney et al, 2016).  
The settings for burst detection in each electrode were a minimum of 5 spikes with a 
maximum inter-spike interval of 0.1 sec as described previously (Jewett et al, 2016). The burst 
duration, number of spikes per burst, and interburst interval were analyzed by AxIS software. 
Synchrony index was also computed through AxIS software, based on a published algorithm 
(Eggermont, 2006) as we conducted previously (Jewett et al, 2016), by taking the cross-
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correlation between any two spike trains, removing the portions of the cross-correlogram that are 
contributed by the auto-correlations of each spike train, and reducing the distribution to a single 
metric.  
To ensure consistency when acquiring MEA data, all the experiment procedures, 
including the animal dissection, cell counting and plating, medium changing, and recordings are 
conducted by the same individual in each experiment. Throughout culture maturation and before 
recording, each MEA is visually inspected under the microscope and any MEA with poor growth 
or a patchy network is excluded. Recordings of each experiment were alternate between 
genotypes. For all before and after drug treatment comparisons, to minimize the variability 
between cultures, the recording from each MEA culture after treatment was compared to the 
baseline recording from that same culture. 
 
2.2.4 Patch-clamp electrophysiology 
Whole-cell patch-clamp recordings were performed by Dr. Kwan Young Lee. The 
recording was made at room temperature (23-25°C) in a submersion chamber continuously 
perfused with artificial cerebrospinal fluid (aCSF) containing (in mM): 119 NaCl, 2.5 KCl, 4 
CaCl2, 4 MgCl2, 1 NaH2PO4, 26 NaHCO3 and 11 D-Glucose, saturated with 95% O2/5% CO2 (pH 
7.4, 310 mOsm). aCSF was supplemented with 1 μM TTX and 100 μM picrotoxin for mEPSC 
measurements to block action potential-dependent EPSCs and GABAA receptors, respectively. 
Whole cell recording pipettes (~4-6 MΩ) were filled with intracellular solution containing (in mM): 
130 K-gluconate, 6 KCl, 3 NaCl, 10 HEPES, 0.2 EGTA, 4 Mg-ATP, 0.4 Na-GTP, 14 Tris-
phosphocreatine, 2 QX-314 (pH 7.25, 285 mOsm). Neurons at DIV 11–14 were used for 
electrophysiological analyses. Membrane potential was clamped at –60 mV. All recordings were 
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performed with Clampex 10.6 and Multiclamp 700B amplifier interfaced with Digidata 1440A 
data acquisition system (Molecular Devices). Recordings were filtered at 1 kHz and digitized at 
10 kHz. Miniature excitatory postsynaptic currents (mEPSCs) were analyzed with Mini Analysis 
Program (Synaptosoft) with a 5-pA threshold level. 
 
2.2.5 Seizure susceptibility 
Male mice at age 4-weeks old were intraperitoneally injected with kainic acid, prepared 
in saline solution (Hannas Pharmaceutical), at doses of 15, 30, or 60 mg/kg. The total injection 
volume was kept close to 0.15 ml.  After injection, mice were closely observed in real time for 1 
hour. The intensity of seizure was assessed by Racine’s scoring system (Racine, 1972). To 
clearly determine seizure susceptibility, only stage 4 (rearing) and stage 5 (rearing and falling) 
were considered positive for seizures, as previously performed (Jewett et al, 2016; Keith et al, 
2012). Mice showing stage 4 seizure and above are counted as 1 while mice showing stage 3 
seizure or under are counted as 0 for analysis. 
 
2.2.6 Statistical analysis 
ANOVA with post-hoc Tukey HSD (Honest Significant Differences) test was used for 
multiple comparisons between treatments or genotypes. Student’s t-test was used for analyzing 
spontaneous neuronal activity in Figs. 2.1B and 2.1C, and mEPSC data in Fig. 2.1D. Each “n” 







2.3.1 Nedd4-2 mediates spontaneous neuronal and synaptic activity 
It is unknown how dysregulation of Nedd4-2 is involved in seizures or epilepsies. To 
answer this question, we employed a mouse model, termed Nedd4-2
andi
, in which the long-form 
(isoform 1) of Nedd4-2 is selectively deleted due to a spontaneous mutation in exon-2 (Fig. 
2.1A). Because Nedd4-2 knockout mice are not viable (Boase et al, 2011), Nedd4-2
andi
 serves as 
an ideal, in vivo knockdown mouse model to study Nedd4-2 function. To assess the question of 
whether Nedd4-2 mediates neuronal activity, we employed a multi-electrode array (MEA) 
recording system (Fig. 2.2) to record extracellular spontaneous spikes of electrical activity in 
primary cortical neuron cultures prepared from WT or Nedd4-2
andi
 mice. As shown in Fig. 2.1B, 
the frequency of spontaneous spikes was significantly elevated in Nedd4-2
andi
 cultures in 
comparison to WT cultures. The average spontaneous spike amplitude did not differ between 
WT and Nedd4-2
andi
 cultures (Fig. 2.1C). These data indicate that spontaneous neuronal activity 
is basally elevated in Nedd4-2
andi
 cortical neuron cultures. 
To determine whether elevated spontaneous neuronal activity in Nedd4-2
andi
 cultures is 
accompanied by altered synaptic transmission, we performed whole-cell patch-clamp recording, 
through collaboration with Dr. Kwan Young Lee in our lab, to obtain miniature excitatory post-
synaptic current (mEPSC) from WT or Nedd4-2
andi
 cortical neuron cultures. As shown in Fig. 
2.1D, Nedd4-2
andi
 neurons exhibit elevation of both mEPSC amplitude and frequency when 
compared to WT neurons. These data suggest that Nedd4-2 likely mediates both pre- and post-
synaptic properties, and the elevation of spontaneous neuronal activity observed in Nedd4-2
andi
 




2.3.2 Nedd4-2 mediates AMPAR-dependent spontaneous neuronal activity 
We previously identified the GluA1 subunit of AMPAR as a novel substrate of Nedd4-2 
(Jewett et al, 2015b). We therefore asked whether AMPAR mediates spontaneous neuronal 
activity and whether it is responsible for the hyperactivity observed in Nedd4-2
andi
 cultures. An 
AMPAR agonist, AMPA (1 µM), was applied to determine how spontaneous neuronal activity 
was affected when AMPAR was activated. MEA recordings from WT cultures before and after 
AMPA treatment for 15 min indicated elevated spontaneous spike frequency (Figs. 2.3A1 and 
2.3A3) suggesting that spontaneous neuronal activity can be modulated by AMPARs. The same 
treatment produced significant, but smaller, effects on Nedd4-2
andi
 cultures (Figs. 2.3A2 and 
2.3A3; Significant interaction between treatment and genotype was detected, p<0.05.). The 
average of spontaneous spike amplitude (Fig. 2.3B) and electrode burst activity did not differ 
after AMPA treatment for either genotype (Fig. 2.4A). These data suggest that Nedd4-2 
contributes to the elevation of spontaneous neuronal activity, particularly spontaneous spike 
frequency, when the AMPAR is activated.  
We then asked whether Nedd4-2
andi
 cultures respond differently when AMPARs are 
pharmacologically inhibited. To this end, we employed a specific AMPAR antagonist, NBQX (2 
µM), and again recorded the spontaneous neuronal activity before and after a 15-min treatment. 
As shown in Fig. 2.5A, NBQX slightly, but not significantly, reduced spontaneous spike 
frequency in WT cultures, while NBQX significantly reduced spike frequency in Nedd4-2
andi
 
cultures (Significant interaction between treatment and genotype was detected, p<0.05.). Again, 
average spontaneous spike amplitude did not differ between either treatments or genotypes (Fig. 
2.5B). Interestingly, we observed elevated burst activity without changes in interburst interval 
(IBI) after NBQX treatment (Fig. 2.4B), which was also observed in another study (Keefer et al, 
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2001). Although we suspect the lack of changes in IBI is potentially because NBQX was applied 
acutely, we did not pursue further experiments with prolonged treatments since our data suggest 
that NBQX-induced burst activity is independent of Nedd4-2 (Figs. 2.4B1 and 2.4B2). 
We previously showed elevated synchrony of spontaneous neuronal activity in Nedd4-
2
andi
 cultures (Jewett et al, 2016). Elevation of synchronized activity indicates potentially 
elevated network activity. To determine whether AMPAR is involved in this phenomenon, we 
analyzed the synchrony index in WT and Nedd4-2
andi
 cultures treated with either AMPA or 
NBQX. As shown in Fig. 2.6, although AMPA treatment elicits some effect toward elevation of 
synchrony, no difference was observed between genotypes. NBQX, on the other hand, produces 
no effect on synchrony in either WT or Nedd4-2
andi
 cultures. These results suggest that, although 
prolonged stimulation of AMPAR might further elevate the synchrony of neuronal activity, the 
effect is unlikely to be Nedd4-2-dependent. Furthermore, AMPAR is also unlikely to be 
responsible for basally elevated synchrony when Nedd4-2 is compromised (Jewett et al, 2016) 
since NBQX exerts no effect. Therefore, whether and how Nedd4-2 mediates synchrony of 
spontaneous neuronal activity or other network activity, such as network spikes and bursts, 
through other substrates would be an important future direction. 
In summary, we showed that Nedd4-2
andi
 cultures were less sensitive to AMPAR 
activation but very sensitive to AMPAR blockade with regard to spontaneous spike frequency. 
These results suggest that altered GluA1/AMPAR signaling in Nedd4-2
andi
 mice contributes to 





2.3.3 Nedd4-2-associated seizures can be normalized when GluA1 is 
genetically reduced 
We have previously demonstrated that Nedd4-2
andi
 mice exhibit greater seizure 
susceptibility induced by systematic administration of kainic acid, a potent agonist for kainate-
class ionotropic glutamate receptors that is widely used to induce seizures in animal models 
(Jewett et al, 2016; Wu et al, 2005). Greater sensitivity to AMPAR blockade in reducing 
spontaneous neuronal activity, as seen in Fig. 2.5, led to our hypothesis that elevated GluA1 
level contributes to elevated seizure susceptibility in Nedd4-2
andi
 mice. To test this hypothesis, 
WT or Nedd4-2
andi



























 mice were reduced by 31% and 46%, respectively, when compared to 
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 mice (Fig. 2.7A). We then determined seizure susceptibility in these mice by 
intraperitoneal injections of kainic acid. Four-week-old mice were injected with kainic acid (15, 
30, or 60 mg/kg) as done in our previous study (Jewett et al, 2016). Behavioral seizures were 



















; Fig. 2.7C, right panel) significantly reduced seizure response in 






; Fig. 2.7C, left panel). 
Furthermore, reducing GluA1 level in Nedd4-2
andi







; Fig. 2.7B, left panel). A slight, but not significant, reduction of 





; Fig. 2.7B, right panel). In conclusion, our results indicate that genetically reducing 






In this study, I present evidence to show that neuronal hyperactivity in vitro and 
increased seizure susceptibility in vivo associated with Nedd4-2 dysfunction are modulated by 
altered GluA1 and AMPAR signaling. Furthermore, because my data showed that genetic 
reduction of GluA1 normalized the seizure response in Nedd4-2
andi
 mice, it suggests that 
inhibition of AMPARs might be a suitable treatment plan for Nedd4-2-associated epilepsy. One 
of the antagonists of AMPAR, Perampanel, has been approved to clinically reduce partial-onset 
seizures with or without secondary generalized seizures in epileptic patients (Chang et al, 2015; 
Rogawski, 2013; Rogawski & Hanada, 2013). Such medication might therefore be specifically 
useful for epilepsy patients who carry mutations in Nedd4-2. A future study on Perampanel will 
be very important to determine whether and to what the extent Nedd4-2-associated seizures 
and/or epilepsy can be ameliorated. 
We used Nedd4-2
andi
 mice, in which the long form of Nedd4-2 is disrupted, to study 
Nedd4-2. Because Nedd4-2 knockout mice exhibit perinatal lethality (Boase et al, 2011), Nedd4-
2
andi
 mice serve as an ideal model to study Nedd4-2 in vivo. However, another question is thus 
raised regarding the differential contribution of long versus short form of Nedd4-2 to the 
regulation of spontaneous neuronal activity and brain circuit excitability. The short form of 
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Nedd4-2, which lacks an N-terminal C2 domain, as shown in Chapter One (Fig. 1.1), has also 
been identified in humans (Dahlberg et al, 2007; Garrone et al, 2009). Indirect evidence has 
suggested that the C2 domain mediates membrane-targeting of Nedd4-2 (Itani et al, 2005). The 
C2-containing (long) and C2-lacking (short) isoforms therefore target different intracellular 
locations and substrate pools (Itani et al, 2005). Currently, it is unclear whether the short form of 
Nedd4-2 exhibits similar affinity toward binding to and ubiquitinating GluA1. If it does, the 
question arises as to whether epilepsy-associated mutations affect the function of C2-lacking 
Nedd4-2 in a similar manner as to the C2-containing Nedd4-2. If it does not, the second question 
is whether the C2-lacking isoform serves as a dominant-negative Nedd4-2 to sequester 
interacting or signaling molecules to affect the functions of the C2-containing Nedd4-2. Because 
single-nucleotide polymorphisms (SNPs) in human Nedd4-2 lead to differential expression of 
these isoforms, examining the functional differences of these isoforms may increase our 
understanding of neuronal plasticity and associated seizure susceptibility in different populations 









Fig. 2.1 Nedd4-2 mediates spontaneous neuronal and synaptic activity. 
(A1) A diagram showing two alternative protein products (isoforms 1 and 2) from the Nedd4-2 gene, and 
(A2) western blot results of Nedd4-2 and Gapdh from brain lysates of WT or Nedd4-2
andi
 mice at age 4-
weeks old. (B) Quantification of spontaneous spike rate (left) and representative raster plots of 
spontaneous spikes from 1-min recording (right) of WT or Nedd4-2
andi
 cortical neuron cultures at DIV 13-
14. (C) Quantification of average spontaneous spike amplitude (left) and representative average traces of 
1-min recording (right) of WT or Nedd4-2
andi
 cortical neuron cultures at DIV 13-14. The black lines 
represent the average of all the spikes within representative 1-min recordings. (D) Patch-clamp recording 
from WT or Nedd4-2
andi
 cortical neurons at DIV 14. Representative mEPSC traces and quantification of 
mEPSC amplitude and frequency are shown (n = 15 for both WT or Nedd4-2
andi
 neurons). Data are 






Fig. 2.2 An example MEA culture. 
(A) A picture of a multi-electrode array (MEA) dish and (B) a representative image of cultured cortical 
neurons growing in a MEA dish at DIV 14. A selected area in (B1) is enlarged and shown in (B2). Images 
were acquired by an EPI-Fluorescence Trinocular Microscope (Omax). (C) Representative 
immunocytochemistry images from WT cortical neurons plated on a separate control plate with the same 
density used in MEA cultures. The dendritic marker MAP2 was stained to show the neuronal processes. 









Fig. 2.3 Acute AMPAR activation triggers stronger elevation of spontaneous neuronal activity in 
WT than Nedd4-2
andi
 cortical neuron cultures. 
(A) Representative raster plots and quantification of spontaneous spikes from 1-min recording (right) of 
(A1) WT or (A2) Nedd4-2
andi
 cortical neuron cultures before and after vehicle (ddH2O) or AMPA (1 µM) 
treatment for 15 min. (Vehicle: n=6 and 9 for WT and Nedd4-2
andi
; AMPA: n=7 and 11 for WT and 
Nedd4-2
andi
) (B) Representative average traces of 1-min recording and quantification of average 
spontaneous spike amplitude of (B1) WT or (B2) Nedd4-2
andi
 cortical neuron cultures before and after 
vehicle (ddH2O) or AMPA (1 µM) treatment for 15 min (Vehicle: n=6 and 9 for WT and Nedd4-2
andi
; 
AMPA: n=7 and 11 for WT and Nedd4-2
andi
). The black lines represent the average of all the spikes 
within representative 1-min recordings. Data are analyzed by a 2-way ANOVA with post-hoc Tukey test 
and represented as mean ± SEM. The comparison between treatments or genotypes is described with 
*p<0.05, ns: non-significant. Significant interaction between treatment and genotype was detected in 





Fig. 2.4 Neuronal burst activity after AMPA or NBQX treatment. 
The bursting activity after the treatment of (A) AMPA (1 μM, 15 min), (B) NBQX (2 μM, 15 min) or 
vehicle control (ddH2O for AMPA and DMSO for NBQX) in WT or Nedd4-2
andi
 cortical neuron cultures 
were measured. Three criteria were used to analyze electrode burst activity: burst duration (left), number 
of spikes per burst (middle) and the interburst interval (right). The data were plotted as “after treatment” 
normalized to “before treatment”. For the quantification, a two-way ANOVA with post-hoc Tukey test 
was used. Data are represented as mean ± SEM. The comparison between treatments or genotypes is 
described with *p<0.05, **p<0.01, ns: non-significant. No significant interaction between treatment and 










 cortical neuron cultures are more sensitive to acute AMPAR blockade than WT 
cultures in reduction of spontaneous neuronal activity. 
(A) Representative raster plots and quantification of spontaneous spikes from 1-min recording (right) of 
(A1) WT or (A2) Nedd4-2
andi
 cortical neuron cultures before and after vehicle (DMSO) or NBQX (2 µM) 
treatment for 15 min. (Vehicle: n=9 and 5 for WT and Nedd4-2
andi
; NBQX: n=8 and 5 for WT and Nedd4-
2
andi
) (B) Representative average traces of 1-min recording and quantification of average spontaneous 
spike amplitude of (B1) WT or (B2) Nedd4-2
andi
 cortical neuron cultures before and after vehicle (DMSO) 
or NBQX (2 µM) treatment for 15 min (Vehicle: n=9 and 5 for WT and Nedd4-2
andi
; NBQX: n=8 and 5 
for WT and Nedd4-2
andi
). The black lines represent the average of all the spikes within representative 1-
min recordings. Data are analyzed by a 2-way ANOVA with post-hoc Tukey test and represented as mean 
± SEM. The comparison between treatments or genotypes is described with **p<0.01, ns: non-significant. 
Significant interaction between treatment and genotype was detected in spontaneous spike rate (A3; 









Fig. 2.6 Synchrony index after AMPA or NBQX treatment. 
The bursting activity after the treatment of (A) AMPA (1 μM, 15 min), (B) NBQX (2 μM, 15 min) or 
vehicle control (ddH2O for AMPA and DMSO for NBQX) in WT or Nedd4-2
andi
 cortical neuron cultures 
were measured. The data were plotted as “after treatment” normalized to “before treatment”. For the 
quantification, a two-way ANOVA with post-hoc Tukey test was used. Data are represented as mean ± 
SEM. No significance was detected between treatments or genotypes (ns: non-significant). No significant 







Fig. 2.7 Genetically reducing GluA1 normalizes elevated seizure susceptibility in Nedd4-2
andi
 mice. 


















Quantification of GluA1 is shown on the right (Six mice of each genotype were obtained for 
quantification. ANOVA with post-hoc Tukey test, **p < 0.01). (B) Four-week old mice with each of the 4 
genotypes mentioned in (A) were intraperitoneally injected with kainic acid (15, 30, or 60 mg/kg). The 
number of mice used in each condition is shown on the top of each bar. Mice showing stage 4 and/or 5 
seizure activity are counted as 1 while mice showing stage 3 seizure or under are counted as 0. The 
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The epilepsy-associated mutations of Nedd4-2 
[Zhu J, Lee KY, Jewett KA, Man HY, Chung HJ, Tsai NP (2017) Epilepsy-associated gene 
Nedd4-2 mediates neuronal activity and seizure susceptibility through AMPA receptors. PLoS 
Genet. 13: e1006634] 
3.1 Introduction 
In the previous chapters, I provided evidence showing the up-regulation of spontaneous 
neuronal activity and seizure susceptibility when Nedd4-2 is reduced in Nedd4-2
andi
 mouse 
model, where those deficits can be corrected when GluA1/AMPAR is pharmacologically or 
genetically inhibited. My data suggest that Nedd4-2 plays a role in ubiquitinating GluA1, and 
impaired GluA1 ubiquitination may be responsible for Nedd4-2-mediated seizure and/ or 
epilepsies. As mentioned in Chapter One, it has been shown that GluA1 ubiquitination 
contributes to its internalization (Lin et al, 2011; Schwarz et al, 2010). This internalization, as 
part of AMPAR trafficking mechanisms (Malenka, 2003), is critical for synaptic depression as 
well as homeostatic regulation of synaptic strength (Anggono et al, 2013; Glebov et al, 2015; 
Henley et al, 2011; McCartney et al, 2014). Moreover, in the case of the three missense 
mutations in Nedd4-2 carried by patients with epilepsy (Dibbens et al, 2007; Vanli-Yavuz et al, 
2015), the mechanisms of whether and how they affect the function of Nedd4-2 still remain 
unclear. Therefore, I hypothesize that the three epilepsy-associated missense mutations of 
Nedd4-2 impair Nedd4-2-dependent ubiquitination and degradation of GluA1, which contributes 
to Nedd4-2-associated seizures and/or epilepsies. 
In this chapter, I first demonstrated that Nedd4-2 ubiquitinates GluA1 and limits its 
surface expression. Then, I generated three Nedd4-2 mutants as reported previously (Dibbens et 
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al, 2007), by Site-Directed Mutagenesis: the first change, cytosine (C) 698 to thymine (T), 
leading to the amino acid substitution S233 to L; the second change, adenine (A) 812 to cytosine 
(C), leading to amino acid substitution E271 to A; the third change, adenine (A)1544 to cytosine 
(C), leading to amino acid substitution H515 to P. As a result, I found that all three missense 
mutations of Nedd4-2 disrupt the 14-3-3-facilitated ubiquitination of GluA1 in HEK cells, and 
fail to reduce surface GluA1 and spontaneous neuronal activity when compared with wild-type 
Nedd4-2. 
These results suggest that the reduction of GluA1 ubiquitination as a crucial deficit 
underlying insufficient function of Nedd4-2 and provide critical information to the development 
of therapies for patients who carry mutations of Nedd4-2. 
 
3.2 Materials and Methods 
3.2.1 Animals and primary cortical neuron cultures 
The Nedd4-2
andi
 mice were obtained from The Jackson Laboratory. Primary cortical 
neuron cultures were made from p0-p1 mice as described previously (Tsai et al, 2012) and 
maintained in NeuralQ basal medium (Sigma) supplemented with 1X B27 supplement 
(Invitrogen), 1X GlutaMax (final concentration at 2 mM; Invitrogen), and Cytosine β-D-
arabinofuranoside (AraC, final concentration at 2 µM; Sigma). The medium was changed 50% 
on DIV 2 and every 3 days thereafter. All experiments using animal data followed the guidelines 
of Animal Care and Use provided by the Illinois Institutional Animal Care and Use Committee 
(IACUC) and the guidelines of the Euthanasia of Animals provided by the American Veterinary 
Medical Association (AVMA) to minimize animal suffering and the number of animals used. 
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This study was performed under an approved IACUC animal protocol of University of Illinois at 
Urbana-Champaign (#14139 to N.-P. Tsai). 
 
3.2.2 Reagents and Constructs 
Recombinant GluA1 and 14-3-3ε were from Origene. Recombinant Nedd4-2 was from 
Abnova. R18 was from Sigma-Aldrich. Cycloheximide, poly-D-lysine and Protein A/G beads 
were from Santa Cruz Biotechnology. The antibodies used in this study were purchased from 
Santa Cruz Biotechnology (anti-α-Tubulin), Cell Signaling (anti-Nedd4-2, anti-pan-14-3-3, anti-
N-cadherin and anti-Ubiquitin), Millipore (anti-GluA1), Thermo Scientific (anti-HA) and 
GenScript Corporation (anti-Gapdh). The epilepsy-associated mutations were generated using 
site-directed mutagenesis reagent (Agilent) to introduce mutations into pCI-HA-Nedd4-2 (Jewett 
et al, 2015b). The primers used are as below: 
S233L: 5’-GGACGTGTCCTCGGAGTTGGACAATAACATCAGAC-3’,  
5’-GTCTGATGTTATTGTCCAACTCCGAGGACACGTCC-3’;  
E271A: 5’- GGGCGGGGATGTCCCCGCGCCTTGGGAGACCATTTC-3’,  
5’- GAAATGGTCTCCCAAGGCGCGGGGACATCCCCGCCC-3’;  
H515P: 5’- CGTTTGAAATTTCCAGTACCTATGCGGTCAAAGACATC-3’,  
5’- GATGTCTTTGACCGCATAGGTACTGGAAATTTCAAACG-3’. 
 
3.2.3 Surface protein biotinylation 
After washing cultured cells with PBS three times, 0.1 mg LLC NHS-LC-BIOTIN (from 
Apexbio Technology) was added to cultures for 30 min. at room temperature. At the end of the 
reaction, cultures were washed with PBS three times. The cell were harvested and lysed in an IP 
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buffer (50 mM Tris, pH 7.4, 120 mM NaCl, 0.5% Nonidet P-40) followed by purification using 
Magnetic Streptavidin Beads (from Cell Signaling). 
 
3.2.4 Transfection, Immunoprecipitation and Western blotting 
HEK cells were transfected using Lipofectamine 3000 (Invitrogen). Primary neuron 
cultures were transduced using lentivirus. WT and mutant Nedd4-2s were sub-cloned into Lenti-
CMV-GFP-2A-Puro Vector (from Applied Biological Materials). Lentivirus was produced in 
HEK cells as described previously (Tsai et al, 2012).  
For immunoprecipitation (IP), cell lysates were obtained by sonicating pelleted cells in IP 
buffer. Eighty µg of total protein or protein mixtures after in vitro ubiquitination was incubated 2 
hours at 4 °C with 0.5 μg primary antibodies. Protein A/G agarose beads were added for another 
hour followed by washing with IP buffer three times. For western blotting, after SDS-PAGE, the 
gel was transferred onto a polyvinylidene fluoride membrane. After blocking with 1% Bovine 
Serum Albumin in TBST buffer (20 mM Tris pH 7.5, 150 mM NaCl, 0.1% Tween-20), the 
membrane was incubated with primary antibody overnight at 4 °C, followed by three 10-min 
washings with TBST buffer. The membrane was then incubated with an HRP-conjugated 
secondary antibody (from Santa Cruz Biotechnology) for 1 hour at room temperature, followed 
by another three 10-min washings. Finally, the membrane was developed with an ECL 
Chemiluminescent Reagent (Jewett et al, 2015b). All the western blot results were semi-






3.2.5 MEA recording  
Each MEA plate was coated with poly-D-lysine for 30 minutes and plated with 2x10
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cells counted using a hemocytometer. Recordings were done at DIV 9 and DIV 14 (Fig. 3.10) in 
the same culture medium using an Axion Muse 64-channel system in single well MEAs (M64-
GL1-30Pt200, Axion Biosystems) inside a 5% CO2, 37°C incubator. Field potentials (voltage) at 
each electrode relative to the ground electrode were recorded with a sampling rate of 25 kHz. 
Right before a recording, if an electrode channel displays excessive “noise” (>10 µV) that 
channel is grounded for the entirety of the recording to avoid interference with other channels 
(McConnell et al, 2012). Due to changes in network activity caused by physical movement of the 
MEA, only the last 15 min of each 30-min recording were used in data analyses. AxIS software 
(Axion Biosystems) was used for the extraction of spikes (i.e. action potentials) from the raw 
electrical signal obtained from the Axion Muse system. After filtering, a threshold of ±7 standard 
deviations was independently set for each channel; activity exceeding this threshold was counted 
as a spike. Only MEAs with more than 2,000 spikes during the last 15 minutes of recording were 
included for data analysis (Jewett et al, 2016; Jewett et al, 2015a). The total spikes obtained from 
each MEA culture was normalized to the number of electrodes, as described in a previous study 
(McSweeney et al, 2016).  
The settings for burst detection in each electrode were a minimum of 5 spikes with a 
maximum inter-spike interval of 0.1 sec as described previously (Jewett et al, 2016). The burst 
duration, number of spikes per burst, and interburst interval were analyzed by AxIS software. 
Synchrony index was also computed through AxIS software, based on a published algorithm 
(Eggermont, 2006) as we conducted previously (Jewett et al, 2016), by taking the cross-
correlation between any two spike trains, removing the portions of the cross-correlogram that are 
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contributed by the auto-correlations of each spike train, and reducing the distribution to a single 
metric.  
To ensure consistency when acquiring MEA data, all the experiment procedures, 
including the animal dissection, cell counting and plating, medium changing, and recordings are 
conducted by the same individual in each experiment. Throughout culture maturation and before 
recording, each MEA is visually inspected under the microscope and any MEA with poor growth 
or a patchy network is excluded. Recordings of each experiment were alternate between 
genotypes. 
 
3.2.6 In vitro ubiquitination 
HA-Ub (Boston Biochem), Ubiquitin Activating Enzyme (UBE1) (Boston Biochem) and 
UbcH5b/UBE2D2 (Boston Biochem) were obtained. Recombinant WT Nedd4-2 was obtained 
from Abcam. When HA-tagged WT or mutant Nedd4-2s were produced in HEK cells, 250 µg of 
total protein lysates were subjected to immunoprecipitation with anti-HA antibody to partially 
purify HA-tagged Nedd4-2s. Recombinant GluA1 (Origene) was used as substrate for in vitro 
ubiquitination with recombinant Nedd4-2 (Fig. 3.6A) or Nedd4-2s obtained from transfected 
HEK cells (Figs. 3.3B and 3.6C) following a protocol previously described (Woelk et al, 2006). 
Recombinant 14-3-3ε was obtained from Origene. 
 
3.2.7 Statistical analysis 
ANOVA with post-hoc Tukey HSD (Honest Significant Differences) test was used for 
multiple comparisons between treatments or genotypes. One-sample t-test was used when 
experimental groups were normalized to control groups, such as western blotting in Fig. 3.2C. 
46 
 




3.3.1 Nedd4-2 ubiquitinates GluA1 at lysine-868 and mediates its surface 
expression 
Our data suggest that impaired GluA1 ubiquitination may be responsible for Nedd4-2-
mediated seizure and/or epilepsies. To test this hypothesis, we sought to characterize the 
functional consequence of GluA1 ubiquitination by Nedd4-2. We first attempted to map the 
Nedd4-2-ubiquitinated residues of GluA1 as ubiquitination at different residues may affect the 
function of GluA1 differently (Fu et al, 2011; Widagdo et al, 2015). We employed human 
embryonic kidney (HEK) cells because they do not express a detectable level of GluA1 or 
Nedd4-2 endogenously (Fig. 3.1). There are four lysine residues (K813, K819, K822, and K868) 
located on the carboxyl-terminal, intracellular domain of GluA1 (Fig. 3.2A) (Lin et al, 2011; 
Schwarz et al, 2010; Widagdo et al, 2015). As reported previously, mutating all four residues 
completely abolishes GluA1 ubiquitination; this rules out other lysine residues as targets 
(Widagdo et al, 2015). Accordingly, WT Nedd4-2 was then co-transfected with WT GluA1 or 
mutant GluA1s in which each lysine was replaced by arginine (R) at each individual site (K813R, 
K819R, K822R and K868R) or all four lysine residues together were mutated to R (4KR). As 
shown in Fig. 3.2B, the GluA1 with either K868R or all four lysine residues mutated to arginine 
(4KR) showed significantly reduced ubiquitination when co-expressed with Nedd4-2. A trend 
toward reduced ubiquitination is also observed when GluA1 carries K822R, suggesting a 
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potential alternative residue for Nedd4-2-mediated ubiquitination. In summary, these results 
suggest that K868 is the most critical residue ubiquitinated by Nedd4-2.  
GluA1 ubiquitination at K868 has been shown to affect its surface expression (Lin et al, 
2011; Schwarz et al, 2010). To determine whether Nedd4-2 mediates surface expression of 
GluA1, we labeled surface proteins with biotin in WT or Nedd4-2
andi
 cortical neuron cultures 
followed by purification of biotinylated proteins with streptavidin beads. As shown in Fig. 3.2C, 
Nedd4-2
andi
 cultures indeed exhibited elevated surface GluA1 when compared with WT cultures. 
N-cadherin serves as a control and did not differ between WT or Nedd4-2
andi
 cultures. These 
results confirm the role of Nedd4-2 in limiting GluA1 surface expression. Because elevated 
surface GluA1 level has been linked to enhanced seizure susceptibility (Brusa et al, 1995; 
Chapman, 2000), our findings further support our hypothesis that altered GluA1 ubiquitination 
contributes to Nedd4-2-associated seizures and/or epilepsies. 
 
3.3.2 Three epilepsy-associated missense mutations reduce Nedd4-2-
mediated GluA1 ubiquitination 
There are three epilepsy-associated missense mutations of Nedd4-2 (S233L, E271A, and 
H515P) identified in patients with epilepsies (Dibbens et al, 2007; Vanli-Yavuz et al, 2015). 
Based on our findings, we aimed to test the hypothesis that one or more of these mutations could 
disrupt GluA1 ubiquitination. To avoid potential inference from other neuronal E3 ligases for 
GluA1 (Rajasekaran et al, 2013; Rajasekaran et al, 2012), we applied reconstitutive systems to 
determine GluA1 ubiquitination using either HEK cells or in vitro ubiquitination. When using 
HEK cells co-transfected with GluA1 and Nedd4-2, we found that GluA1 is less ubiquitinated 
when co-expressed with any of the Nedd4-2 mutants in comparison to WT Nedd4-2 (Figs. 3.3A 
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and 3.4). When in vitro ubiquitination was performed using recombinant full-length GluA1 with 
WT or any of the expressed Nedd4-2 mutants (partially purified from HEK cells), we also found 
that in comparison to WT Nedd4-2, all three mutant Nedd4-2s exhibited reduced ability to 
ubiquitinate GluA1 in vitro (Fig. 3.3B).  
Previously we showed that Nedd4-2-mediated-GluA1 ubiquitination leads to degradation 
of GluA1 (Jewett et al, 2015b). To determine whether mutant Nedd4-2s fail to degrade GluA1, 
HEK cells were co-transfected with GluA1 and WT or mutant Nedd4-2. Using cycloheximide 
(100 µg/ml) to inhibit protein translation and follow protein degradation, significant GluA1 
down-regulation is only observed when co-expressed with WT Nedd4-2 but not with any of the 
mutant Nedd4-2s (Fig. 3.3C). Slightly enhanced levels of GluA1 or Nedd4-2 after cycloheximide 
treatment were observed in some groups after normalization with the internal control Tubulin. 
This is due to a lower turnover rate of GluA1 or Nedd4-2 than that of Tubulin when cells were 
transfected with mutant Nedd4-2s. To strengthen the idea that GluA1 degradation is altered when 
co-expressed with mutant Nedd4-2s, HEK cells co-transfected with GluA1 and WT or mutant 
Nedd4-2 were treated with proteasome inhibitor MG132 (10 µM) (Fig. 3.5). GluA1 significantly 
accumulates when co-expressed with WT Nedd4-2, but not with any of the mutant Nedd4-2s, 
after MG132 treatment. Altogether, our data suggest that all three missense mutations disrupt 
Nedd4-2-mediated GluA1 ubiquitination and degradation. 
 
3.3.3 Three epilepsy-associated missense mutations of Nedd4-2 disrupt 
14-3-3-facilitated GluA1 ubiquitination 
When expressing WT or mutant Nedd4-2s in HEK cells, it was observed that the mutant 
Nedd4-2s exhibited increased basal levels and reduced degradation when compared with WT 
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Nedd4-2 (Figs. 3.3C3 and 3.5), suggesting enhanced stability. Because Nedd4-2 can self-
ubiquitinate, the reduced down-regulation of both GluA1 and Nedd4-2 suggests that these 
missense mutations most likely affect the general ubiquitination process mediated by Nedd4-2 
(Bruce et al, 2008; Cui & Zhang, 2013). Furthermore, all three mutations are located on or near 
one of the three protein-protein interaction domains (WW domain) in Nedd4-2, as shown in 
Chapter One (Fig. 1.1), suggesting potentially altered interaction with its interacting proteins. To 
test this possibility, we studied the adaptor protein 14-3-3, which directly interacts with Nedd4-2 
and has been shown to mediate Nedd4-2’s substrate recognition (Chandran et al, 2011; Liang et 
al, 2006; Nagaki et al, 2006). We first aimed to determine whether 14-3-3 mediates Nedd4-2-
mediated GluA1 ubiquitination. In vitro ubiquitination using recombinant GluA1 and Nedd4-2 
yielded some GluA1 ubiquitination (Fig. 3.6A1, lane 1). Remarkably, in the presence of 
recombinant 14-3-3ε, one of the 14-3-3 isoforms known to interact with Nedd4-2 (Liang et al, 
2008a), GluA1 ubiquitination was significantly enhanced (Fig. 3.6A1, lane 2). To validate the 
role of 14-3-3, a peptide-based general 14-3-3 inhibitor, R18 trifluoroacetate (R18; 0.025 mg/ml), 
which is known to disrupt the interaction between 14-3-3 and its binding partners, was used 
(Dong et al, 2008; Du et al, 2008; Fujita et al, 2003). As predicted, R18 reduced GluA1 
ubiquitination to a level similar to Nedd4-2 alone (Fig. 3.6A1, lane 4). For controls, the same 
reactions in the absence of either Nedd4-2 or ubiquitin showed nearly undetectable GluA1 
ubiquitination (Fig. 3.6A1, lanes 5‒8). These data suggest that, while Nedd4-2 is capable of 
ubiquitinating GluA1 in the absence of 14-3-3, 14-3-3 significantly facilitates this ubiquitination. 
We then asked whether reduced GluA1 ubiquitination by epilepsy-associated missense 
mutations of Nedd4-2 occurred through altered interactions with 14-3-3. WT or mutant Nedd4-2 
was transfected into HEK cells. Co-immunoprecipitation showed that all three mutants have 
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reduced interactions with endogenous 14-3-3 in HEK cells (Fig. 3.6B). Similar results were 
obtained when using recombinant 14-3-3ε to immunoprecipitate WT or mutant Nedd4-2 
expressed in HEK cells (Fig. 3.7). To determine whether the Nedd4-2 mutants fail to respond to 
14-3-3 when ubiquitinating GluA1, in vitro ubiquitination using recombinant GluA1 and WT or 
mutant Nedd4-2 partially purified from HEK cells was performed. While WT Nedd4-2 strongly 
ubiquitinated GluA1 and responded to additional 14-3-3ε with further GluA1 ubiquitination, all 
of the mutant Nedd4-2s failed to do so (Fig. 3.6C). Because the level of 14-3-3 does not seem to 
be regulated by Nedd4-2 (Fig. 3.8), our results suggest that the epilepsy-associated missense 
mutations of Nedd4-2 disrupt GluA1 ubiquitination, at least partially through reduced interaction 
with 14-3-3. 
 
3.3.4 Three epilepsy-associated missense mutations of Nedd4-2 fail to 
regulate surface GluA1 and spontaneous neuronal activity 
Because the epilepsy-associated missense mutations of Nedd4-2 disrupt GluA1 
ubiquitination and degradation, we hypothesize that these mutations fail to mediate surface 
GluA1 and spontaneous neuronal activity. To this end, we performed surface protein 
biotinylation to obtain and measure surface GluA1 from WT cortical neuron cultures lentivirally 
transduced with WT or mutant Nedd4-2 for 5 days. Surprisingly, no significant effect was 
observed (Fig. 3.9). We suspect that the level of Nedd4-2 during early development might reach 
a threshold in WT cultures, and therefore expression of additional Nedd4-2 fails to elicit 
significant effects. Furthermore, because mutant Nedd4-2s exhibit significantly reduced affinity 
toward interacting with 14-3-3 and therefore GluA1 (Figs. 3.3 and 3.6), they might not be 
dominant-negative, at least in the context of GluA1 ubiquitination. The endogenous Nedd4-2 in 
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WT cultures potentially dominates even in the presence of mutant Nedd4-2s. Therefore, to 
determine the effects of mutant Nedd4-2s without the interference from endogenous Nedd4-2, 
we repeated this experiment in Nedd4-2
andi
 cortical neuron cultures. Using Nedd4-2
andi
 cultures 
possesses the advantage of studying the behavior of mutant Nedd4-2s while minimizing the 
concern of overexpression. As shown in Fig. 3.10A, WT Nedd4-2 significantly reduced total and 
surface GluA1 in Nedd4-2
andi
 cultures while all three mutant Nedd4-2s showed no effect. When 
expressing WT Nedd4-2 or any of the mutant Nedd4-2s in Nedd4-2
andi
 cortical neuron cultures 
for 5 days, we found that the cultures transduced with WT Nedd4-2 showed significantly lower 
spontaneous spike frequency when compared with untransduced cultures or cultures transduced 
with any of the mutant Nedd4-2s (Figs. 3.10B1 and 3.10B2). The average spontaneous spike 
amplitude did not differ between transduced and untransduced cultures. Altogether, our data 
showed that the three epilepsy-associated missense mutations of Nedd4-2 disrupt the ability to 
regulate surface GluA1 and spontaneous neuronal activity. 
 
3.4 Discussion 
In this study, I present evidence to show that three epilepsy-associated missense 
mutations of Nedd4-2 partially, but significantly, disrupted GluA1 ubiquitination through 
reduced interaction with the adaptor protein 14-3-3. All mutant Nedd4-2s retain partial function 
toward ubiquitinating GluA1, reflecting the fact that the mutations were located on or near 
protein-protein interaction domains but not the lipid-binding or catalytic HECT (Homologous to 
the E6-AP Carboxyl Terminus) domain. Nevertheless, this is the first report that demonstrates a 
mechanism to explain Nedd4-2-dependent epilepsy in patients. Although the mutations of 





 mice), I showed that the reduction of Nedd4-2 and the mutations each reduce 
the ability of Nedd4-2 to ubiquitinate GluA1. 
In the adult brain, the AMPAR has been shown to mediate the majority of excitatory 
synaptic transmission with GluA1 being one of the major subunits (Zhu et al, 2000). Activity-
mediated changes in the numbers and properties of GluA1/AMPAR are essential for excitatory 
synapse development and synaptic plasticity. Ubiquitination of GluA1 has been linked to 
AMPAR surface expression and trafficking, which subsequently may affect many synaptic 
plasticity mechanisms, such as homeostatic synaptic scaling and synaptic depression (Briz et al, 
2015; Davis, 2013; Lin et al, 2011; Schwarz et al, 2010; Widagdo et al, 2015). We previously 
demonstrated that Nedd4-2 mediates GluA1 ubiquitination upon chronic neuronal activity 
stimulation, suggesting a potential role of Nedd4-2 in homeostatic synaptic downscaling (Jewett 
et al, 2015b). Whether Nedd4-2 participates in other synaptic plasticity mechanisms is unknown. 
One speculation would be that because Nedd4-2 functions to limit the amount of surface GluA1 
as seen in Fig. 3.2C, neuronal activity that mediates depression or elimination of excitatory 
synapses might induce Nedd4-2-mediated GluA1 ubiquitination. We recently found that the 
expression of Nedd4-2 is modulated by another ubiquitin E3 ligase murine double minute-2 
(Mdm2) and its downstream effector tumor suppressor p53 (Jewett et al, 2015b). Mdm2 is 
known to be crucial for activity-dependent synapse elimination (Tsai et al, 2012), which is 
crucial for brain circuit development and maturation. Activation of Mdm2-p53 signaling and 
Nedd4-2 expression might therefore contribute to elimination of excitatory synapses. Further 
studies are required to delineate the broader effects of Nedd4-2. 
In addition to GluA1, other neuronal substrates of Nedd4-2 potentially involved in 
neuronal activity regulation are voltage-gated sodium channels Nav1.6 and voltage-gated 
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potassium channels Kv7.3/KCNQ3 (Ekberg et al, 2007; Ekberg et al, 2014; Goel et al, 2015; 
Schuetz et al, 2008). These two substrates are both crucial to modulating action potential firing 
and intrinsic excitability. Although our data showed that GluA1 mediates Nedd4-2-associated 
neuronal hyperactivity and seizures in mice, it does not rule out the potential contributions of 
Nav1.6 and Kv7.3/KCNQ3 in Nedd4-2-associated brain circuit excitability. Our data also suggest 
that presynaptic defects are potentially involved in the neuronal deficits associated with Nedd4-2, 
as shown in Chapter Two (Fig. 2.1D).  Multiple substrates of Nedd4 family members are known 
to mediate presynaptic vesicle release and activity, including α-synuclein (Kim et al, 2016; 
Tardiff et al, 2013; Tofaris et al, 2011) and tyrosine kinase A receptors (Barker-Gibb et al, 2001; 
Georgieva et al, 2011; Yu et al, 2014). Altered ubiquitination of these substrates when Nedd4-2’s 
function is compromised could contribute to aberrant synaptic transmission. The ubiquitination 
status, expression level, and subcellular distribution of Nedd4-2’s other substrates are pending 
further investigation to obtain the full picture of synaptic abnormality and excitability caused by 
pathogenic functions of mutant Nedd4-2s. As we described previously, future studies are 
expected to elucidate broader effects of Nedd4-2 and provide better understanding of this 











Fig. 3.1 HEK cells do not express detectable level of Nedd4-2 or GluA1. 
Western blots of Nedd4-2, GluA1, and Actin from WT cortical neuron culture lysate or HEK cell lysate. 






Fig. 3.2 Nedd4-2 mediates surface expression of GluA1. 
(A) Illustration of GluA1 on the cell membrane and the 4 lysine residues potentially ubiquitinated by 
Nedd4-2 at the C-terminus of GluA1. (B1) Western blots of Ubiquitin (Ub) or GluA1 after 
immunoprecipitation using anti-GluA1 antibody from HEK cells transfected with WT HA-Nedd4-2 along 
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Fig. 3.2 (cont.) 
with WT GluA1 or mutant GluA1s (K813R, K819R, K822R, K868R and 4KR) for 48 hours. 
Quantification of ubiquitinated GluA1 by the area of smear from 100 – 250 kDa is shown on the right (B2) 
(n = 4, one-way ANOVA with post-hoc Tukey test). (C) Western blots of GluA1, N-cadherin, and Actin 
from WT or Nedd4-2
andi
 cortical neuron cultures. Proteins from total lysate or after surface biotinylation 
were as indicated (n = 3, one-sample t-test was performed after normalization to WT groups). For all 











Fig. 3.3 Three epilepsy-associated missense mutations of Nedd4-2 reduce GluA1 ubiquitination. 
(A1) Western blots of Ubiquitin (Ub) or GluA1 after immunoprecipitation using anti-GluA1 antibody 
from HEK cells transfected with GluA1 along with HA-tagged WT or mutant Nedd4-2 for 48 hours. 
Quantification of ubiquitinated GluA1 by the entire area of smear from 100 – 250 kDa is shown on the 
right (A2) (n = 4, one-way ANOVA with post-hoc Tukey test). (B1) Western blots of Ub or GluA1 after 
immunoprecipitation with anti-GluA1 antibody following in vitro ubiquitination with recombinant GluA1. 
HA-tagged WT or mutant Nedd4-2s used for in vitro ubiquitination were obtained from HEK cells 
transfected with one of the Nedd4-2s followed by immunoprecipitation with anti-Nedd4-2 antibody. 
Quantification of ubiquitinated GluA1 by the entire area of smear (B2) and Coomassie blue staining 
showing the purity of recombinant GluA1 (B3) are shown (n = 4, one-way ANOVA with post-hoc Tukey 
test). (C1) Western blots of GluA1 and Nedd4-2 after cycloheximide treatment over an 8-hr time course. 
HEK cells were transfected with GluA1 and HA-tagged WT or mutant Nedd4-2s for 48 hours. Cells were 
then treated with cycloheximide (100 µg/ml) to inhibit protein translation and follow protein degradation. 
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Fig. 3.3 (cont.) 
Representative western blots after 0- and 8-hr cycloheximide treatment (C1) and time courses of GluA1 
(C2) and Nedd4-2 (C3) levels after cycloheximide treatment are shown. Analyses were performed by 
comparing GluA1 or Nedd4-2 level at each time point between cultures receiving different Nedd4-2s (n = 
4, one-way ANOVA with post-hoc Tukey test). For all experiments, data are represented as mean ± SEM 





Fig. 3.4 K868 of GluA1 is the major residue ubiquitinated by Nedd4-2. 
Western blots of Ubiquitin (Ub) or GluA1 after GluA1 immunoprecipitation from HEK cells transfected 
with WT or mutant Nedd4-2s along with WT- or K868R-GluA1 for 48 hours. Quantification of 
ubiquitinated GluA1 by the entire area of smear from 100–250 kDa is shown on the right (n = 4). 
Student’s t-test was used for comparison between WT- and K868R-GluA1 in each group. One-way 
ANOVA with post-hoc Tukey test was used for comparison between different Nedd4-2s. Data are 









Fig. 3.5 Three epilepsy-associated missense mutations of Nedd4-2 reduce GluA1 degradation. 
Representative western blots of GluA1, Nedd4-2, and Actin from HEK cells transfected with GluA1 
along with WT or mutant Nedd4-2s after 0- and 8-hr MG132 (10 μM) treatment are shown. The data 
were plotted as “after treatment” normalized to “before treatment”. The quantification of GluA1 and 
Nedd4-2 levels after MG132 treatment are on the right (n = 4, one-way ANOVA with post-hoc Tukey 









Fig. 3.6 Three epilepsy-associated missense mutations of Nedd4-2 disrupt 14-3-3-facilitated GluA1 
ubiquitination. 
(A1) Western blots of Ub or GluA1 after immunoprecipitation with anti-GluA1 antibody following in 
vitro ubiquitination with recombinant GluA1 and Nedd4-2, and in the presence or absence of recombinant 
14-3-3ε, 14-3-3 inhibitor R18, or Ubiquitin as labeled. Quantification of lanes 1-4 by the entire area of 
smear from 100 – 250 kDa (A2) and Coomassie blue staining showing the purity of recombinant Nedd4-2 
and 14-3-3ε (A3) (n = 4, 2-way ANOVA with post-hoc Tukey test). (B1) Western blots of Nedd4-2 or 14-
3-3 after a co-immunoprecipitation using anti-14-3-3 antibody with the lysate of HEK cells transfected 
with HA-tagged WT or mutant Nedd4-2s for 48 hours. Input of transfected Nedd4-2s, endogenous 14-3-3, 
and Tubulin are shown on the bottom. Quantification of immunoprecipitated Nedd4-2 (B2) is shown on 
the right (n = 4, one-way ANOVA with post-hoc Tukey test). (C1) Western blots of Ub or GluA1 after 
immunoprecipitation with anti-GluA1 antibody following in vitro ubiquitination with recombinant GluA1 
in the presence or absence of recombinant 14-3-3ε. HA-tagged WT or mutant Nedd4-2s used for in vitro 
ubiquitination were obtained from HEK cells transfected with one of the Nedd4-2s followed by 
immunoprecipitation with anti-Nedd4-2 antibody. Right before the washing, 1/10 of reaction mixture was 
obtained and used as input control shown on the bottom. (C2) The intensity of ubiquitinated GluA1 by the 
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Fig. 3.6 (cont.) 
entire area of smear from 100 – 250 kDa is normalized to the WT group in the absence of 14-3-3ε (lane 3 
on the representative blot C1). The difference in each group with or without the addition of 14-3-3ε was 









Fig. 3.7 Three epilepsy-associated missense mutations of Nedd4-2 exhibit reduced interaction with 
14-3-3. 
Western blots of Nedd4-2 and 14-3-3 (pan) after using recombinant 14-3-3ε to immunoprecipitate Nedd4-
2 from the lysates of HEK cells transfected with WT or mutant Nedd4-2s for 48 hours. Right before the 
washing, 5% of total protein mixture was obtained and used as input control shown on the bottom. 
Quantification is on the right (n = 3, one-way ANOVA with post-hoc Tukey test). Data are represented as 







Fig. 3.8 Nedd4-2 does not regulate the level of 14-3-3. 
Western blots of Nedd4-2, 14-3-3, and Actin from WT or Nedd4-2
andi
 brain lysates. Quantification is 










Fig. 3.9 Overexpression of WT or mutant Nedd4-2 in WT cortical neuron cultures does not affect 
endogenous AMPAR level. 
(A) Western blots of GluA1, N-cadherin, HA-Nedd4-2, and Actin from WT cultures lentivirally 
transduced with or without WT or mutant Nedd4-2s for 5 days starting at DIV 9. Proteins from total 
lysate or after surface biotinylation were as indicated. Quantification of (B) total and (C) surface GluA1 
are on the right (n = 3, one-way ANOVA with post-hoc Tukey test). Data are represented as mean ± SEM. 








Fig. 3.10 Three epilepsy-associated missense mutations of Nedd4-2 fail to mediate surface GluA1 
level and spontaneous neuronal activity. 
(A1) Western blots of GluA1, N-cadherin, HA-Nedd4-2, and Actin from Nedd4-2
andi
 cultures lentivirally 
transduced with or without WT or mutant Nedd4-2s for 5 days starting at DIV 9. Proteins from total 
lysate or after surface biotinylation were as indicated. Quantification of (A2) total and (A3) surface GluA1 
are on the right (n = 4, one-way ANOVA with post-hoc Tukey test). (B1) Representative raster plots, (B2) 
quantification of spontaneous spike rate from 1-min recording and (B3) quantification of average 
spontaneous spike amplitude of Nedd4-2
andi
 cortical neuron cultures lentivirally transduced with or 
without WT or mutant Nedd4-2s for 5 days starting at DIV 9 (n = 5-7, one-way ANOVA with post-hoc 
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Nedd4-2 isoforms regulate excitatory synaptic strength 
through different mechanisms 
[Zhu J, Lee KY, Jong TT, Tsai NP (2019) C2-lacking isoform of Nedd4-2 regulates excitatory 
synaptic strength through GluA1 ubiquitination-independent mechanisms. J Neurochem. 151: 
289-300] 
4.1 Introduction 
As mentioned in previous chapters, Nedd4-2 is an epilepsy-associated gene, which 
encodes a ubiquitin E3 ligase (Allen et al, 2013). The mechanism by which Nedd4-2 disruption 
or mutations lead to seizures and/or epilepsies was unclear until our recent discovery of the 
GluA1 subunit of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPA 
receptor; AMPAR) as a new substrate of Nedd4-2 (Zhu et al, 2017). Using a mouse model, 
termed Nedd4-2
andi
, in which the predominant form of Nedd4-2 (the full-length Nedd4-2) in the 
brain is deficient, it was shown that both GluA1 and seizure susceptibility were elevated. Most 
importantly, genetic reduction of GluA1 normalizes seizure susceptibility in Nedd4-2-deficient 
mice (Zhu et al, 2017). These findings suggest AMPAR is a key substrate of full-length Nedd4-2 
in the regulation of brain circuit excitability and introduce a critical role of Nedd4-2 at post-
synapses. However, knowledge of other Nedd4-2 isoforms in the brain remains limited.  
Another major isoform of Nedd4-2, in which a N-terminal C2 domain is missing, has also 
been identified in both human and rodent models (Dahlberg et al, 2007; Garrone et al, 2009). 
This C2-lacking isoform is believed to be expressed through a different mRNA transcript with 
the amino acids encoded from exons 1 to 6 of the full-length Nedd4-2 transcript were omitted 
due to the use of a different translation initiation codon (Fu et al, 2013). The C2 domain is 
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known to interact with negatively charged phospholipids and therefore commonly guides the 
protein to the plasma membrane (Corbalan-Garcia & Gomez-Fernandez, 2014). Due to this 
interaction, C2-containing proteins often interact with membrane-associated proteins, such as ion 
channels and membrane receptors, and participate in cell–cell communication and intracellular 
signaling pathways. This is particularly important for the nervous system in which large amount 
of ion channels are expressed and constantly require dynamic regulation. As our previous studies 
reported, the C2-containing, full-length, Nedd4-2 interacts with and ubiquitinates GluA1, and 
negatively regulates excitatory synaptic strength in the hippocampus and cortex (Lee et al, 2018). 
Nevertheless, it is unclear whether Nedd4-2’s C2-lacking isoform could play a role in excitatory 
synapses and/or neurons. Because single-nucleotide polymorphisms (SNPs) in human Nedd4-2 
lead to differential expression of the C2-containing and C2-lacking isoforms (Dahlberg et al, 
2007; Garrone et al, 2009), examining their functional differences may aid our understanding of 
neuronal excitability regulation and seizure susceptibility in different populations. 
In the current study, we showed that the C2-lacking Nedd4-2 showed a reduced 
distribution at cell membranes and extremely low affinity in ubiquitinating GluA1. Surprisingly, 
we found that the C2-lacking Nedd4-2 exhibits similar activity toward reducing excitatory 
synaptic strength when compared to the C2-containing Nedd4-2. Using proteomic screening, we 
identified multiple potential substrates of the C2-lacking Nedd4-2 in the cytoplasm, including 
calcineurin A that could mediate excitatory synaptic strength (Woolfrey & Dell'Acqua, 2015). 
Our findings therefore indicate that both C2-containing and C2-lacking Nedd4-2s function to 
reduce excitatory synaptic strength although most likely via distinct mechanisms. These results 
further support our conclusion in which we speculated that Nedd4-2-associated neuronal 
hyperexcitability and seizure susceptibility are critically influenced by elevated excitatory 
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synaptic transmission when the functions of Nedd4-2, both C2-containing and C2-lacking 
isoforms, are compromised. 
 
4.2 Materials and Methods 
4.2.1 Animals and genotyping 
All experiments using animal data followed the guidelines of Animal Care and Use 
provided by the Illinois Institutional Animal Care and Use Committee (IACUC) and the 
guidelines of the Euthanasia of Animals provided by the American Veterinary Medical 
Association (AVMA) to minimize animal suffering and the number of animals used. This study 
was performed under an approved IACUC animal protocol of University of Illinois at Urbana-
Champaign (#14139 and #17075 to N.-P. Tsai). 
WT mice in C57BL/6J (RRID: IMSR_JAX:000664), BALB/c (RRID: 
IMSR_JAX:001026), 129S1 (RRID: IMSR_JAX:002448) background, and Emx1-Cre mice 
(RRID: IMSR_JAX:022762) in C57BL/6J background were obtained from The Jackson 
Laboratory. Nedd4-2 floxed mice were generated and obtained from Dr. Hiroshi Kawabe (Max 
Planck Institute). For genotyping, the primers used to detect Nedd4-2 loxP allele are: 5’-
TCCCCACTGCAGTTCCTACC-3’, and 5’-AGCTGCTCAGGCTGAATCACC-3’. PCR was 
performed using the program as below: 3 min at 94°C; 5 cycles of 20 sec at 94°C, 20 sec at 65°C, 
2 min at 72°C; 5 cycles of 20 sec at 94°C, 20 sec at 60°C, 2 min at 72°C; 25 cycles of 20 sec at 
94°C, 20 sec at 55°C, 2 min at 72°C; and 10 min at 72°C. The primers used to detect Emx1 allele 
are 5’-CGGTCTGGCAGTAAAAACTATC-3’ (Emx1-Cre), 5’-
GTGAAACAGCATTGCTGTCACTT-3’ (Emx1-Cre); 5’-AAGGTGTGGTTCCAGAATCG-3’ 
(Wild type), and 5’-CTCTCCACCAGAAGGCTGAG-3’ (Wild type). The PCR program is as 
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below: 2 min at 94°C; 10 cycles of 20 sec at 94°C, 15 sec at 65°C (with 0.5°C per cycle 
decrease), 10 sec at 68°C; 28 cycles of 15 sec at 94°C 15 sec at 60°C, 10 sec at 72°C; and 2 min 
at 72°C. 
 
4.2.2 Reagents and cell culture 
Dimethyl sulfoxide (DMSO) was from Thermo Fisher Scientific (catalog: BP231-100). 
Tetrodotoxin citrate (TTX) was from Cayman Chemicals (catalog: 14964). Ionomycin was from 
AdipoGen (catalog: AG-CN2-0416-M001). The antibodies used in this study were purchased 
from Cell Signaling (anti-Nedd4-2, RRID: AB_1904063; anti-pan-14-3-3, RRID: AB_10860606; 
anti-Myc, RRID: AB_490778; anti-N-Cadherin, RRID: AB_2798427; anti-HA, RRID: 
AB_10691311, and anti-Ub, RRID: AB_331292), Millipore (anti-GluA1-N-terminus, RRID: 
AB_1977459), Santa Cruz Biotechnology (anti-α-tubulin, RRID: AB_628411), and Proteintech 
(anti-Gapdh, RRID: AB_2107436), and ABclonal (anti-PPP3CA, RRID: AB_2758155). Human 
embryonic kidney (HEK 293) cells were from ATCC (ATCC #CRL-1573, RRID: CVCL_0045). 
HEK 293 cell line is not listed as a commonly misidentified cell line by the International Cell 
Line Authentication Committee (ICLAC) and was not authenticated in this study. Cells were 
cultured in Dulbecco's Modified Eagle Medium (Sigma, catalog: 10017CV) with 10% Fetal 
Bovine Serum (JM Bioscience, catalog: 100-500). Cells were used between passages 4 to 25 and 
kept at 37°C in a humidified incubator containing 5% CO2. 
 
4.2.3 Constructs 
The C2-containing, full-length, Nedd4-2 (pCI-HA-Nedd4-2) was obtained from Addgene 
(RRID: Addgene_27000). The C2-lacking Nedd4-2 was PCR-amplified using pCI-HA-Nedd4-2 
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as the template and the primer pair (5’-CCGGTACCGAGCGACCCTATACATTTAAG-3’ and 
5’-CGAAGCGGCCGCTTAATC-3’) into KpnI/NotI sites of pCI vector. The C2-lacking Nedd4-
2 carrying epilepsy-associated mutations were generated with same method above but using pCI-
HA-Nedd4-2s that carry those mutations, constructed previously (Zhu et al, 2017), as templates. 
Amplification was performed in a thermal cycler using the following program: 1 cycle of 3 min 
at 95°C; 35 cycles of 30 sec at 95°C, 30 sec at 55°C, 2 min 30 sec at 72°C, and 1 cycle of 10 
min at 72°C. 
 
4.2.4 In vitro ubiquitination 
HA-Ub (Boston Biochem, catalog: U-110), Ubiquitin Activating Enzyme (UBE1) 
(Boston Biochem, catalog: E-305) and UbcH5b/UBE2D2 (Boston Biochem, catalog: E2-622) 
were obtained. When HA-tagged C2-lacking Nedd4-2 was produced in HEK cells, 250 µg of 
total protein lysates were subjected to immunoprecipitation with anti-HA antibody to partially 
purify HA-tagged C2-lacking Nedd4-2. Recombinant PPP3CA (Sino Biological, catalog: 13670-
H07B) was used as substrate for in vitro ubiquitination with C2-lacking Nedd4-2 obtained from 
transfected HEK cells following a protocol previously described (Woelk et al, 2006). 
 
4.2.5 Primary neuron cultures 
Primary neuron cultures were made from mixed-sex mice aged at p0-p1 as described 
previously (Liu et al, 2017) and maintained in NeuralA basal medium (Thermo Fisher, catalog: 
10888022) supplemented with B27 supplement (Invitrogen, catalog: 17504001), GlutaMax (final 
concentration at 2 mM; Invitrogen, catalog: 35050061), and Cytosine β-D-arabinofuranoside 
(AraC, final concentration at 2 µM; Sigma, catalog: C1768-100MG). Each set of cultures was 
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made by pooling 4-6 cortices before plating into multiple 35-mm petri dishes depending on the 
need of each experimental. Each experiment was performed using sister cultures made from the 
same litter. The culture medium was changed 50% on days-in-vitro (DIV) 2 and every 3-4 days 
thereafter until the experiments on DIV 14-16. 
 
4.2.6 Proteomics 
The proteomic screening was conducted using cytoplasmic fractions of WT and Nedd4-2 
conditional knockout mouse brains with label-free analyses provided by Bioproximity. In brief, 
after adding trypsin at a ratio of 1:50 to the samples, and the solution was incubated at 37°C 
overnight. The peptides were then extracted, lyophilized and resuspended in 2-20 μL of 0.1% 
formic acid. Ultra performance liquid chromatography - tandem mass spectrometer (UPLC-
MS/MS) was then carried out by Easy-nLC1200 and HF-X Hybrid Quadrupole-Orbitrap Mass 
Spectrometer. The raw data files were analyzed and searched against uniprot-Mus musculus 
protein databases. 
 
4.2.7 Membrane protein extraction 
Membrane protein extraction assay was conducted by the Mem-PER Plus Membrane 
Protein Extraction Kit (Thermo Scientific, catalog: 89842) and according to manufacturer’s 
protocol with minor modification. Cortical neuron cultures at DIV 14 or whole brains were 
harvested in 1 mL of Cell Wash Solution. After washing and a centrifuge at 300×g for 5 min, cell 
or tissue pellet was resuspended in 500 μL of Permeabilization Buffer. The cell or tissue 
suspension was then incubated at 4 °C for 10 min with constant rotation. Permeabilized cells 
were subjected to a centrifuge for 15 min at 16,000×g at 4°C. The supernatant containing 
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cytoplasmic proteins was transferred to a clean tube and saved as cytoplasmic fractions. The 
pellet was resuspended in 300 μL of Solubilization Buffer by pipetting up and down, followed by 
an incubation of 10 min at 4°C with constant rotation. After another centrifuge at 16,000×g for 
15 min at 4℃, the supernatant containing solubilized membrane and membrane-associated 
proteins was collected. 
 
4.2.8 Whole-cell patch-clamp recording 
Whole-cell patch-clamp recordings were performed by Dr. Kwan Young Lee, as we 
previous described (Jewett et al, 2018; Tsai et al, 2017), at room temperature (23-25°C) in a 
submersion chamber continuously perfused with artificial cerebrospinal fluid (aCSF) containing 
(as in mM): 119 NaCl, 2.5 KCl, 4 CaCl2, 4 MgCl2, 1 NaH2PO4, 26 NaHCO3 and 11 D-Glucose, 
saturated with 95% O2/5% CO2 (pH 7.4, 310 mOsm). aCSF was supplemented with 1 μM TTX 
and 100 μM picrotoxin for mEPSC measurements to block action potentials and GABAA 
receptors, respectively. Whole cell recording pipettes (~4-6 MΩ) were filled with intracellular 
solution containing (as in mM): 130 K-gluconate, 6 KCl, 3 NaCl, 10 HEPES, 0.2 EGTA, 4 Mg-
ATP, 0.4 Na-GTP, 14 Tris-phosphocreatine, 2 QX-314 (pH 7.25, 285 mOsm). Neurons at DIV 14–
16 were used for electrophysiological analyses. Membrane potential was clamped at –60 mV. 
Neurons were excluded in analyses when the resting membrane potential was > –45 mV, access 
resistance was > 30 MΩ, or if access resistance changed by > 20%. All recordings were 
performed with Clampex 10.6 and Multiclamp 700B amplifier interfaced with Digidata 1440A 
data acquisition system (Molecular Devices). Recordings were filtered at 1 kHz and digitized at 
10 kHz. Miniature excitatory postsynaptic currents (mEPSCs) were analyzed with Mini Analysis 
Program (Synaptosoft) with a 5-pA threshold level. 
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4.2.9 Transfection, immunoprecipitation and western blotting 
For transient transfection, HEK 293 and primary cortical neurons were transfected using 
Lipofectamine 3000 (Invitrogen, catalog: L3000015). Specifically for neurons, cells were 
transfected at DIV 11 (for electrophysiology experiments) for 60 minutes followed by replacing 
the culture medium with conditioned medium to minimize toxicity produced by Lipofectamine. 
For immunoprecipitation (IP), HEK cell lysates were obtained by sonicating pelleted cells in an 
IP buffer (50 mM Tris, pH 7.4, 120 mM NaCl, 0.5% Nonidet P-40). One hundred µg of total 
protein was incubated 2 hours at 4 °C with 0.5 μg antibodies. Protein A/G agarose beads (from 
Santa Cruz Biotechnology, RRID: AB_10201400) were added for another hour followed by 
washing with IP buffer three times. Samples of immunoprecipitation or cell lysates were then 
mixed in a buffer (40% Glycerol, 240 mM Tris/HCl pH 6.8, 8% sodium dodecyl sulfate, 0.04% 
bromophenol blue and 5% β-mercaptoethanol) and boiled for 5 min. After cooling down on ice 
for another 5 min, the samples were loaded onto 8% sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) gels. For Western blotting, after SDS-PAGE, the gel was 
transferred onto a polyvinylidene fluoride membrane. After blocking with a 1% Bovine Serum 
Albumins (from Thermo Fisher Scientific, catalog: BP9706100) solution in TBST buffer (20 
mM Tris pH 7.5, 150 mM NaCl, 0.1% Tween-20), the membrane was incubated with primary 
antibody overnight at 4 °C, followed by a 30-min washing with PBS on the next day. The 
membrane was then incubated with an HRP-conjugated secondary antibody (from Cell Signaling, 
RRID: AB_330924) in 5% non-fat milk in TBST for 1 hour at room temperature, followed by 





4.2.10 Statistical Analysis 
At least 3 litters, 4-6 mice each, were used in each experiment. Due to the design of our 
research, no blinding was performed. The data presented in this study have been tested for 
normality using Kolmogorov-Smirnov Test. Statistical methods to determine significance along 
with sample numbers were indicated in each figure legend. In brief, Student’s t-test was used for 
paired samples and one sample t-test was used for conditions where experimental groups are 
normalized to control groups. One-way ANOVA with post-hoc Tukey HSD (Honest Significant 
Differences) test was used for multiple comparisons. A Grubbs' outlier test was conducted on the 
data and, as a result, one data point in Fig. 4.7C was removed. Prism software (RRID: 




4.3.1 C2-lacking Nedd4-2 has reduced association with membranes 
Studies have reported the observation of two major Nedd4-2 splice variants (isoforms 1 
and 2) in human and rodent models (Dahlberg et al, 2007; Garrone et al, 2009). The proteins 
encoded by these two transcripts are predicted to be roughly 20 kDa different in molecular 
weight. The long-form, encoded by isoform 1, contains a N-terminal C2 domain while the short-
form, encoded by isoform 2, does not (Fig. 4.1A). We confirmed the co-existence of these two 
protein isoforms in multiple commonly used mouse models, including C57BL/6J, BALB/c, and 
129S1 mice (black, white, and brown mice, respectively) (Fig. 4.1B). We chose C57BL/6J for 
the rest of our experiments due to the same genetic background as other transgenic mouse 
models that will be used later in this study.  
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The C2 domain is involved in targeting proteins to cell membranes (Corbalan-Garcia & 
Gomez-Fernandez, 2014), and Nedd4-2 has many membrane-associated substrates reported 
previously (Manning & Kumar, 2018). In order to determine whether the C2-lacking isoform of 
Nedd4-2 indeed showed less association with membranes, we isolated total membrane fractions 
from wildtype (WT) C57BL/6J mouse brains. As shown, in comparison to C2-lacking Nedd4-2, 
the C2-containing Nedd4-2 showed much higher distribution in membrane-enriched fractions, 
supporting the possibility that the C2-containing and C2-lacking Nedd4-2s function differently in 
the brain. 
 
4.3.2 C2-lacking Nedd4-2 represses excitatory synaptic strength 
We previously showed that the C2-containing Nedd4-2 is capable of ubiquitinating the 
GluA1 subunit of AMPA receptors (Zhu et al, 2017) and reducing excitatory synaptic strength 
(Lee et al, 2018). In order to determine whether and the way in which the C2-lacking Nedd4-2 
functions to affect excitatory synaptic transmission, we transiently expressed C2-containing or 
C2-lacking Nedd4-2 into primary cortical neuron cultures prepared from WT C57BL/6J mice. 
Forty-eight hours after transfection, we used whole-cell patch-clamp recording in order to obtain 
miniature excitatory post-synaptic currents (mEPSC). As shown in Fig. 4.2, neurons receiving 
either C2-containing or C2-lacking Nedd4-2 showed significant reductions in mEPSC amplitude 
without changes in mEPSC frequency (Fig. 4.3) when compared to control neurons receiving 
only green fluorescence protein (GFP). These results indicate that C2-lacking Nedd4-2 can 
function to limit excitatory synaptic strength in a manner similar to C2-containing Nedd4-2. 
To further determine whether the effect of C2-lacking Nedd4-2 on mEPSC amplitude is 
dependent on C2-containing Nedd4-2, we expressed C2-lacking Nedd4-2 in the absence of C2-
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containing Nedd4-2. To this end, we first obtained Nedd4-2 conditional knockout (cKO) mice by 
crossing Nedd4-2 floxed mice (Nedd4-2
f/f
) with Emx1-Cre mice. Emx1-Cre can confer Nedd4-2 
reduction in the cortex and hippocampus beginning as early as embryonic 10.5 (E10.5) (Gorski 





cultures was confirmed in Fig. 4.4A. We subsequently expressed C2-containing or C2-lacking 
Nedd4-2 into Nedd4-2 cKO cultures, followed by mEPSC recordings. As shown (Figs. 4.4B-D 
and 4.5), both C2-containing and C2-lacking Nedd4-2 are capable of reducing mEPSC amplitude 
without changes in mEPSC frequency. These data conclude that the effect of C2-lacking Nedd4-
2 isoform on reducing mEPSC amplitude is independent of C2-containing Nedd4-2. 
 
4.3.3 C2-lacking Nedd4-2 has low activity toward ubiquitinating GluA1 
Because C2-containing Nedd4-2 ubiquitinates GluA1, it is logical to speculate that C2-
lacking Nedd4-2 may also ubiquitinate GluA1 to repress excitatory synaptic strength as we 
showed in Fig. 4.2. To this end, we employed human embryonic kidney (HEK 293) cells, which 
do not express Nedd4-2 or GluA1 endogenously, to determine whether C2-lacking Nedd4-2 can 
ubiquitinate GluA1. As shown in Fig 4.6A, in comparison to being co-expressed with C2-
containing Nedd4-2, the GluA1 co-expressed with C2-lacking Nedd4-2 exhibited significantly 
lower ubiquitination. Because GluA1 ubiquitination negatively affects the amount of GluA1 on 
the cell membrane (Lin et al, 2011; Schwarz et al, 2010), we also determined the amount of 
GluA1 associated with membrane when co-expressed with either isoform of Nedd4-2s. As 
shown in Fig. 4.6B, in comparison to being co-expressed with C2-containing Nedd4-2, the 
GluA1 co-expressed with C2-lacking Nedd4-2 exhibited a significantly higher level in the 
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membrane fractions. These results conclude that C2-lacking Nedd4-2 has a relatively low 
affinity for ubiquitinating GluA1. 
Nedd4-2 is known to interact with multiple isoforms of the adaptor protein 14-3-3 
(Ichimura et al, 2005; Liang et al, 2008b; Liang et al, 2006) and we have previously shown that 
C2-containing Nedd4-2 requires 14-3-3 in order to interact with GluA1 (Lee et al, 2018; Zhu et 
al, 2017). In order to determine whether C2-lacking Nedd4-2 has a reduced interaction with 14-
3-3, we expressed C2-containing or C2-lacking Nedd4-2 into HEK cells followed by co-
immunoprecipitation with an anti-pan 14-3-3 antibody. As shown in Fig. 4.6C, C2-lacking 
Nedd4-2 exhibited significantly lower association with 14-3-3 in comparison to C2-containing 
Nedd4-2. Together, our results suggest that C2-lacking Nedd4-2 shows significantly reduced 
activity toward ubiquitinating GluA1, which could be due to a reduced interaction with one or 
multiple isoforms of the adaptor protein 14-3-3. 
Nedd4-2’s sub-cellular distribution and substrate recognition are known to be mediated 
by calcium (Ca
2+
) influx (Boehmer et al, 2003; Wang et al, 2010). This is particularly apparent 
for C2-containing Nedd4-2 because the C2 domain binds to Ca
2+
, which subsequently leads to 
enhanced membrane interaction with C2-containing Nedd4-2 (Garrone et al, 2009). In order to 
determine whether GluA1 ubiquitination by C2-containing and C2-lacking Nedd4-2s is 
modulated by Ca
2+
 influx, we utilized ionomycin, a Ca
2+
 ionophore, which has been shown to 
efficiently affect membrane distribution of Nedd4-2 in Xenopus (Garrone et al, 2009). We first 
aimed to evaluate whether ionomycin treatment facilitated the targeting of Nedd4-2 to membrane 
compartments in neurons. As shown in Fig. 4.7A, primary cortical neuron cultures treated with 
ionomycin (1 µM, 1 hr) exhibited no significant difference in distribution of C2-containing and 
C2-lacking Nedd4-2 in the membrane fractions. Similar results were obtained when we 
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employed HEK cells transfected with C2-containing or C2-lacking Nedd4-2 followed by 
ionomycin treatment for 1 hr (Fig. 4.7B). These results suggest that the membrane distribution of 
Nedd4-2 might be differentially regulated in mammalian cells, as opposed to the Xenopus cells 
(Garrone et al, 2009). However, when we studied GluA1 ubiquitination in HEK cells, we found 
that GluA1 ubiquitination was significantly elevated when GluA1 was co-expressed with C2-
containing but not C2-lacking Nedd4-2 (Fig. 4.7C). The results suggest that despite the absence 
of significant changes in Nedd4-2’s association with membranes, Ca
2+
 influx promotes C2-
containing Nedd4-2-mediated ubiquitination of GluA1. This could potentially be resulted from 
the crosstalk between Ca
2+
 and 14-3-3, as the functions of 14-3-3 are known to be affected by 
Ca
2+
 (Li et al, 2019; Zhitomirsky et al, 2018). The results, together with our findings in Fig. 4.6, 
led to our hypothesis in which C2-lacking Nedd4-2 represses excitatory synaptic strength most 
likely through GluA1 ubiquitination-independent mechanisms. 
 
4.3.4 Unbiased proteomic screening identifies potential substrates of 
Nedd4-2 in regulating synaptic strength 
In order to identify potential mechanisms by which C2-lacking Nedd4-2 represses 
excitatory synaptic strength, we decided to search for novel Nedd4-2 substrates using an 
unbiased proteomic approach. To this end, we obtained cytoplasmic fractions from whole brains 








) littermate mice 
(Fig. 4.8A) for quantitative proteomic profiling. From two pairs of Nedd4-2 WT and cKO 
littermate mice, we obtained quantitative measurements for a total of 414 proteins that were 
detected in all four mice. Among those proteins, 34 proteins exhibited at least a two-fold increase, 
and 15 proteins exhibited at least a 50% reduction in Nedd4-2 cKO compared to WT (Fig. 4.8B 
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and Table 4.1). Further, among those proteins with obvious changes in expression levels, eight of 
them have known functions that affect excitatory synaptic transmission through pre-synaptic 
and/or post-synaptic mechanisms (Fig. 4.8C). Up-regulation of some or all of these proteins in 
the Nedd4-2 cKO brain could explain altered excitatory synaptic strength in neurons transfected 
with Nedd4-2. Further studies would be needed to characterize the relationship between Nedd4-2 
and each of its potential substrates. 
 
4.3.5 C2-lacking Nedd4-2 ubiquitinates PPP3CA  
In order to begin testing the possibility that C2-lacking Nedd4-2 ubiquitinates one of the 
proteins that we identified in Fig. 4.8C, we chose to study protein phosphatase 3 catalytic 
subunit-α (PPP3CA) or alternatively called calcineurin A-α. PPP3CA is encoded by an epilepsy-
associated gene (Mizuguchi et al, 2018), and has been shown to either positively or negatively 
affect synaptic strength (Kim & Ziff, 2014; Szabo et al, 2010). To first validate that PPP3CA is a 
potential substrate of Nedd4-2, we examined ubiquitination of endogenous PPP3CA in Nedd4-2 
WT and cKO mouse cortices. As shown in Fig. 4.9A, the ubiquitination of PPP3CA is drastically 
reduced in Nedd4-2 cKO cortex. To further examine the Nedd4-2-mediated ubiquitination of 
PPP3CA, we co-expressed C2-lacking Nedd4-2 and a Myc-tagged PPP3CA into HEK cells 
followed by immunoprecipitation with anti-Myc antibody and western blotting with anti-Ub 
antibody. As shown (Fig. 4.9B), strong PPP3CA ubiquitination was observed when co-expressed 
with C2-lacking Nedd4-2, and such ubiquitination presumably leads to proteasomal degradation 
(Fig. 4.10). Similar ubiquitination of PPP3CA was also observed when the Myc-tagged PPP3CA 
was co-expressed with C2-containing Nedd4-2 (Fig. 4.11), suggesting PPP3CA is likely a 
substrate of both C2-containing and C2-lacking Nedd4-2s. To strengthen the conclusion that 
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PPP3CA is a direct substrate of C2-lacking Nedd4-2, we conducted an in vitro ubiquitination 
assay with full-length, recombinant, His-tagged PPP3CA protein and C2-lacking Nedd4-2 
proteins (partially purified from HEK cells). As shown in Fig. 4.9C, the ubiquitination of 
PPP3CA is elevated in the presence of C2-lacking Nedd4-2. All these results above indicate 
PPP3CA is a substrate of C2-lacking Nedd4-2. 
We followed these experiments with additional testing as to whether three reported 
epilepsy-associated mutations on Nedd4-2 can affect PPP3CA ubiquitination. To this end, we 
generated expression constructs of C2-lacking Nedd4-2 carrying either of the three missense 
mutations (S233L, E271A, or H515P). These mutations, located on or near one of the three WW 
domains (protein-protein interaction domains), have been shown to affect the substrate binding 
affinity of C2-containing Nedd4-2 (Zhu et al, 2017), and we hypothesize that some or all of these 
mutations could disrupt PPP3CA ubiquitination. As shown in Fig. 4.9D, in comparison to WT 
C2-lacking Nedd4-2, PPP3CA exhibited significantly lower ubiquitination when co-expressed 
with either of the mutant C2-lacking Nedd4-2s. These results indicate that the epilepsy-
associated mutations can alter the ubiquitination of substrates of both C2-containing and C2-
lacking Nedd4-2s. Because these mutations do not affect the ubiquitination of a voltage-gated 
sodium channel by Nedd4-2 (Dibbens et al, 2007), it suggests the impairment resulted from these 
mutations is likely substrate-dependent. Altogether, our findings support the likelihood that C2-
lacking Nedd4-2 ubiquitinates one or more synaptic regulators leading to down-regulation of 







Our current study explored the functions of a C2-lacking isoform of Nedd4-2 in neurons. 
We found that despite a similar function toward reducing excitatory synaptic strength as the C2-
containing Nedd4-2, the C2-lacking Nedd4-2 exhibits a much lower activity toward 
ubiquitinating GluA1. This is consistent with our data showing significantly reduced interaction 
between C2-lacking Nedd4-2 and 14-3-3, the adaptor protein necessary for Nedd4-2-dependent 
GluA1 ubiquitination (Zhu et al, 2017). Using an unbiased proteomic approach, we identified 
several potential new substrates of Nedd4-2 and confirmed one of them, PPP3CA, as a new 
substrate of the C2-lacking Nedd4-2. When PPP3CA is ubiquitinated, it is presumably degraded 
in the proteasome. However, to mechanistically understand other downstream effects when 
PPP3CA is ubiquitinated by Nedd4-2, a future study to generate mutant PPP3CAs that cannot be 
ubiquitinated by Nedd4-2 after mapping out the lysine residue(s) ubiquitinated by Nedd4-2 
would be particularly important. In the current study, we showed that three epilepsy-associated 
mutations of Nedd4-2 disrupted PPP3CA ubiquitination, suggesting that dysregulation of 
PPP3CA, which is encoded by an epilepsy-associated gene, may contribute to Nedd4-2-
associated epilepsy. Our data also suggest that those epilepsy-associated mutations on Nedd4-2, 
which are carried in both C2-containing and C2-lacking Nedd4-2 transcripts, may have much 
stronger effects on dysregulating excitatory synaptic strength than we initially expected as we 
now know that both isoforms function to repress synaptic strength. Although our data suggest 
that the C2-lacking Nedd4-2 does not directly ubiquitinate GluA1, many of the potential 
substrates of Nedd4-2 that we identified could indirectly affect the trafficking or stability of 
AMPARs, leading to altered excitatory synaptic strength. For example, PPP3CA is involved in 
GluA1 dephosphorylation (Kam et al, 2010), which is known to affect GluA1/AMPAR function 
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(Goel et al, 2011; Machado et al, 2018). Adducin-1 is another protein shown to regulate AMPAR 
through modulation of its stability (Vukojevic et al, 2012). As a future direction, it would be of 
particular importance to further study the role of C2-lacking Nedd4-2 in AMPAR trafficking and 
stability, so we may develop therapies to properly treat patients who carry mutations in Nedd4-2. 
Our data showed that C2-lacking Nedd4-2 primarily resides in non-membrane 
compartments as we predicted based on the lipid-binding property of C2 domain. Using 
proteomic screening, we indeed identified multiple potential substrates of Nedd4-2 that are 
primarily located in the cytoplasm (Fig. 4.8C and Table 4.1). Among those, 14-3-3 epsilon is 
particularly interesting. 14-3-3 is known to be crucial to Nedd4-2-dependent ubiquitination 
(Ichimura et al, 2005; Liang et al, 2008b; Liang et al, 2006; Zhu et al, 2017). 14-3-3 epsilon 
being a potential substrate of Nedd4-2 indicates a possibility that the C2-lacking Nedd4-2 may 
regulate the substrate recognition of both C2-lacking and C2-containing Nedd4-2s through 
ubiquitination of its own adaptor protein. To determine whether this possibility adds another 
layer of regulation toward GluA1 ubiquitination and synaptic hyperexcitability, we would need 
future work to first determine which isoform of 14-3-3 is more critical to Nedd4-2-dependent 
ubiquitination of GluA1. Although 14-3-3 epsilon and many other proteins identified in our 
proteomic screening may contribute to Nedd4-2-associated hyperexcitability when Nedd4-2 is 
compromised in epilepsy patients, we may still miss many other yet-to-be identified substrates of 
Nedd4-2 due to the limitation of proteomic approaches along with the low expression levels that 
are involved in regulation of synaptic strength. In addition, many studies have confirmed that 
protein ubiquitination can affect protein functions without causing protein degradation (Miranda 
& Sorkin, 2007). With this notion, we may be missing substrates of Nedd4-2 that are 
functionally altered without being up-regulated in Nedd4-2 cKO mice. Other types of approaches, 
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such as use of co-immunoprecipitation followed by mass spectrometry analyses, may be useful 
for identifying binding partners that could be substrates of Nedd4-2. 
Because of membrane-binding capacity of Nedd4-2, many membrane proteins have been 
identified as the direct substrates of Nedd4-2 in various organs, including brain, lung, and kidney 
(Manning & Kumar, 2018). Specifically in the brain, several ion channels, such as voltage-gated 
sodium channels Nav1.6 and voltage-gated potassium channels Kv7.2/Kv7.3 (KCNQ2/3), have 
been shown to be ubiquitinated by Nedd4-2 (Ekberg et al, 2007; Ekberg et al, 2014; Goel et al, 
2015; Schuetz et al, 2008), and could be involved in Nedd4-2-dependent excitability regulation. 
Although the C2-lacking Nedd4-2 may not be in a close proximity with those ion channels on 
cell membranes, it remains to be determined whether C2-lacking Nedd4-2 can interact with 
endocytosed ion channels and subsequently regulates their ubiquitination and overall neuronal 
excitability. Although our current study provides the first evidence to demonstrate the function of 
C2-lacking Nedd4-2 in neurons, future studies are clearly needed in order to further characterize 











Fig. 4.1 C2-lacking Nedd4-2 has reduced association with membranes in comparison to C2-
containing Nedd4-2. 
(A) A diagram showing two alternative protein products from the Nedd4-2 gene and their domains. (B) 
Western blots of Nedd4-2 and Gapdh from total brain lysates of C57BL/6J, BALB/c and 129S1 mice. (C) 
Western blots of Nedd4-2, N-Cadherin and Gapdh from membrane fractions of C57BL/6J mouse brains. 
For the analysis, a one-sample t-test was used (n = 4 mouse brains). Data are represented as mean ± SEM 











Fig. 4.2 C2-lacking Nedd4-2 suppresses excitatory synaptic transmission. 
(A-C) Patch-clamp recording from WT mouse cortical neurons transfected with GFP, GFP+C2-
containing Nedd4-2 and GFP+C2-lacking Nedd4-2 for 48 hours. Representative miniature excitatory 
postsynaptic current (mEPSC) traces (A), cumulative probability of mEPSC amplitude (B) and 
quantification of mEPSC amplitude (C) are shown (n = 14-16 cells from 3 independent cultures). Data 
were analyzed using a one-way ANOVA with Tukey test and represented as mean ± SEM with *p < 0.05, 












Fig. 4.3 Overexpressing C2-containing or C2-lacking Nedd4-2 does not affect mEPSC frequency. 
Patch-clamp recording from WT mouse cortical neurons transfected with GFP, GFP+C2-containing 
Nedd4-2 and GFP+C2-lacking Nedd4-2 for 48 hours. Quantification of mEPSC frequency is shown (n = 
14-16 cells). Data were analyzed using a one-way ANOVA with Tukey test and represented as mean ± 








Fig. 4.4 C2-lacking Nedd4-2 suppresses excitatory synaptic transmission independent of C2-
containing Nedd4-2. 









) cortical neuron cultures (DIV 14). (B-D) Patch-clamp recording from Nedd4-2 cKO 
mouse cortical neurons transfected with GFP, GFP+C2-containing Nedd4-2 and GFP+C2-lacking Nedd4-
2 for 48 hours. Representative miniature excitatory postsynaptic current (mEPSC) traces (B), cumulative 







Fig. 4.4 (cont.) 
cells from 4 independent cultures). Data were analyzed using a one-way ANOVA with Tukey test and 










Fig. 4.5 Overexpressing C2-containing or C2-lacking Nedd4-2 in Nedd4-2 cKO neurons does not 
affect mEPSC frequency. 




) cortical neurons transfected with 
GFP, GFP+C2-containing Nedd4-2 and GFP+C2-lacking Nedd4-2 for 48 hours. Quantification of 
mEPSC frequency is shown (n = 22-23 cells). Data were analyzed using a one-way ANOVA with Tukey 









Fig. 4.6 C2-lacking Nedd4-2 exhibits significantly lower activity toward ubiquitinating GluA1. 
(A) Western blots of ubiquitin (Ub) after immunoprecipitation using anti-GluA1 antibody from HEK cells 
transfected with GluA1, GluA1+C2-containing Nedd4-2 or GluA1+C2-lacking Nedd4-2 for 48 hours (n = 
5 sets of cell culture dishes from 4 independent preparations). (B) Western blots of GluA1, Nedd4-2, N-
Cadherin and Gapdh from total cell lysates and membrane fractions of HEK cells transfected with GluA1 
along with C2-containing or C2-lacking Nedd4-2 for 48 hours (n = 4 sets of cell culture dishes from 2 
independent preparations). (C) Western blots of Nedd4-2 after co-immunoprecipitation of 14-3-3 using 
lysates from HEK cells transfected with C2-containing or C2-lacking Nedd4-2 for 48 hours (n = 4 sets of 
cell culture dishes from 4 independent preparations). Data were analyzed using Student’s t-test and 
represented as mean ± SEM with *p < 0.05. 
  





Fig. 4.7 Calcium influx does not promote membrane association of, or GluA1 ubiquitination by, C2-
lacking Nedd4-2. 
(A) Western blots of Nedd4-2, N-Cadherin and Gapdh from membrane and cytoplasm fractions of WT 





Fig. 4.7 (cont.) 
dishes from 3 independent preparations). (B) Western blots of Nedd4-2, N-Cadherin and Gapdh from 
membrane and cytoplasm fractions of HEK cells transfected with C2-containing or C2-lacking Nedd4-2 
for 48 hours followed by DMSO or ionomycin (1 μM) treatment for 1 hour (n = 3 sets of cell culture 
dishes from 3 independent preparations). (C) Western blots of ubiquitin (Ub) after immunoprecipitation 
using anti-GluA1 antibody from HEK cells transfected with GluA1+C2-containing Nedd4-2 or 
GluA1+C2-lacking Nedd4-2 for 48 hours followed by DMSO or ionomycin (1 μM) treatment for 1 hour 
(n = 9 sets of cell culture dishes from 5 independent preparations). Data were analyzed using Student’s t-










Fig. 4.8 Proteomic screening to identify potential substrates of Nedd4-2 in the cytoplasm. 









) mouse brains. (B) A pie chart 
summarizing the proteomic screening results using the cytoplasmic fractions from two pairs of Nedd4-2 
WT and Nedd4-2 cKO mouse brains. (C) A heat map showing the levels of 8 proteins potentially 
involved in regulation of excitatory synaptic transmission and regulated by Nedd4-2. 
 
  








Fig. 4.9 C2-lacking Nedd4-2 ubiquitinates PPP3CA. 









) mouse brain lysates. (B) Western blots of ubiquitin (Ub) 
after immunoprecipitation using anti-Myc antibody from HEK cells without transfection or transfected 
with Myc-PPP3CA or Myc-PPP3CA+C2-lacking Nedd4-2 for 48 hours. (C) Western blots of Ub or His 
after immunoprecipitation with anti-His antibody following in vitro ubiquitination with recombinant 
PPP3CA. HA-tagged C2-lacking Nedd4-2 used for in vitro ubiquitination were obtained from HEK cells 







Fig. 4.9 (cont.) 
Coomassie blue staining showing the purity of recombinant PPP3CA is shown. (D) Western blots of 
ubiquitin (Ub) after immunoprecipitation using anti-Myc antibody from HEK cells transfected with Myc-
PPP3CA along with WT C2-lacking Nedd4-2 or C2-lacking Nedd4-2 carrying one of the three epilepsy-
associated missense mutations for 48 hours (n = 4 sets of cell culture dishes from 4 independent 
preparations). Data were analyzed using a one-way ANOVA with Tukey test and represented as mean ± 









Fig. 4.10 PPP3CA can be degraded in the proteasome. 
Western blots of Nedd4-2, Myc-PPP3CA and Gapdh from HEK cells transfected with C2-lacking Nedd4-
2 and Myc-PPP3CA and treated with DMSO or MG-132 (10 µM) for 16 hours. (n = 4 cell cultures from 2 
independent preparations). Data were analyzed using Student’s t-test and represented as mean ± SEM 







Fig. 4.11 C2-containing Nedd4-2 can also ubiquitinate PPP3CA. 
Western blots of ubiquitin (Ub) after immunoprecipitation using anti-Myc antibody from HEK cells 
transfected with Myc-PPP3CA alone or Myc-PPP3CA+C2-lacking Nedd4-2 or Myc-PPP3CA+C2-






Table 4.1: Proteins with >2 fold or <0.5 fold changes in Nedd4-2 cKO mice in comparison to Nedd4-
2 WT mice. 
Protein description cKO / WT (fold) 
Synaptotagmin-1 isoform 2 5.97703614 
Zinc finger C2HC domain-containing protein 1A 5.917297727 
Gpi1 protein 4.823431478 
Ulip4 protein 4.627177531 
60S ribosomal protein L36 4.619858878 
Glucose-6-phosphate isomerase 4.035472587 
14-3-3 epsilon 3.96021784 
40S ribosomal protein S19 3.955793338 
Oxidation resistance protein 1 isoform G 3.686445632 
Rab3a protein 3.570052258 
Ubiquitin B 3.347919313 
Amphiphysin 3.199060836 
hepatoma-derived growth factor isoform 1 3.087231477 
visinin-like protein 1 2.988402492 
60 kDa heat shock protein, mitochondrial 2.803794355 
Synaptojanin-1 2.777544381 
Furin 2.619749394 
GDP-dissociation inhibitor 2.574317527 
Ribosomal protein L27A 2.550047426 
26S proteasome regulatory subunit 7 2.527027996 
Adenylate kinase isoenzyme 1 isoform 1 2.488952782 
Dihydropyrimidinase-related protein 4 2.468053741 
60S ribosomal protein L6 2.438720593 
Pleiotrophin precursor 2.36809213 
Proliferation-associated protein 2G4 2.351111581 
Heat shock protein 90, beta (Grp94), member 1 2.271174562 
Protein phosphatase 3, catalytic subunit, alpha isoform 2.204850502 
Fructose-bisphosphate aldolase C 2.180761411 
Serpina1a protein 2.115388258 
Dihydropyrimidinase-like 5 2.085986294 
V-type proton ATPase subunit B, brain isoform 2.075413688 
Obg-like ATPase 1 2.071166731 
Adenylyl cyclase-associated protein 1 2.016201101 
Adducin 1 (alpha) 2.000735967 
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Table 4.1 (cont.) 
Protein description cKO / WT (fold) 
Myotrophin 0.482553146 
Aspartate aminotransferase, cytoplasmic 0.457259953 
Potassium-transporting ATPase alpha chain 1 isoform 1 0.447515869 
Peptidyl-prolyl cis-trans isomerase FKBP3 0.406925546 
Receptor expression-enhancing protein 5 0.40469295 
Hexokinase 0.402631625 
Serine/threonine-protein phosphatase 2A regulatory subunit A  0.400009549 
Transgelin-3 0.385974985 
DARPP-32 0.334294587 
Glutamate dehydrogenase 1 0.333175414 
Novel amplified in breast cancer-1 0.28232129 
RUN and FYVE domain containing 3 0.16835858 
Glutamine synthetase 0.143324617 
SKD2 0.141391143 
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Conclusion and Discussion 
5.1 Conclusion and Discussion 
To summarize the findings from previous chapters, we first showed in a mouse model 
(termed Nedd4-2
andi
 mice), in which the expression of Nedd4-2 is reduced, that the neuronal 
network activity and seizure susceptibility are basally up-regulated, less responsive to AMPAR 
activation, and much more sensitive to AMPAR blockade. We also demonstrated that the 
elevated seizure susceptibility in Nedd4-2
andi
 mice can be normalized when GluA1 is genetically 
reduced. Moreover, three epilepsy-associated missense mutations of Nedd4-2 disrupt the 
ubiquitination of GluA1 and fail to reduce spontaneous neuronal activity in vitro. Finally, we 
showed that both common isoforms of Nedd4-2 function to reduce the strength of excitatory 
synapses: while C2-containing isoform likely exerts this effect through down-regulating 
AMPAR, C2-lacking isoform may do so through regulating other synaptic regulators. 
Despite our discovery, there are also certain experimental methods we used that could be 
improved, as well as some other experiments that could be done to better support our hypothesis. 
To begin with, it would be interesting to characterize the neuronal network activity of Nedd4-2 
cKO neurons. Since both isoforms of Nedd4-2 are absent in Nedd4-2 cKO mice, using Nedd4-2 
cKO cultures would better mimic the constitutive dysfunction of Nedd4-2 in epilepsy patients 
whose both isoforms of Nedd4-2 are compromised. In addition, it would be also important to test 
the susceptibility to kainic acid-induced seizures in Nedd4-2 cKO mice and test to what extent 
knocking down GluA1 is sufficient to reduce seizure response in Nedd4-2 cKO mice. 
110 
 
In regards to our research with proteomic screening, it would be more ideal if we could 
include the samples from Nedd4-2
andi
 mice for analysis and comparison. As the Nedd4-2
andi
 mice 
only express the C2-lacking Nedd4-2 isoform, comparing the changes in proteins between 
Nedd4-2
andi




 (Nedd4-2 cKO) mice may reveal specific substrates of 
C2-lacking isoform of Nedd4-2.  
As mentioned in Chapter Four, PPP3CA is one of the potential substrates of Nedd4-2 that 
we identified through the proteomic screening. Ppp3ca is also an epilepsy-associated gene 
(Myers et al, 2017), encoding the alpha isoform of a subunit of calcineurin, a 
calcium/calmodulin-regulated serine/threonine protein phosphatase. Calcineurin plays a crucial 
role in many biological processes, including synaptic vesicle trafficking and recycling. It has 
been reported that calcineurin mediates the removal of GABAA receptors from cell surface 
through interacting with γ2 subunit (Eckel et al, 2015). This indicates that the reduction of 
surface GABAA receptors, resulted from elevated levels of calcineurin, might be responsible for 
the epileptiform activity seen when Nedd4-2 is genetically or functionally reduced. Therefore, 
calcineurin could be a potential target for developing new therapeutic strategies. One of the 
future directions would be to test whether the neuronal network activity in Nedd4-2 cKO neurons 
can be reduced upon treatment with a calcineurin inhibitor. It would also be of particular interest 
to test whether the seizure susceptibility in Nedd4-2 cKO mice could be reduced when PPP3CA 
is genetically reduced or when calcineurin is pharmacologically inhibited. Obtaining results from 
these experiments would further demonstrate the regulation of neuronal excitability by Nedd4-2-
calcineurin pathway. Since Ppp3ca knockout (Ppp3ca
-/-
) mice are available (Kayyali et al, 1997), 
we could cross Nedd4-2 WT or cKO mice with Ppp3ca
-/-
 mice to genetically reduce PPP3CA in 
the presence or absence of Nedd4-2. Through MEA recordings, patch-clamp electrophysiology 
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and seizure susceptibility experiments as we described in Chapter Two and Chapter Four, we 
would be able to determine the extent to which dysregulation of PPP3CA contributes to elevated 
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